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Chapter 1
General introduction
1.1 Image-guided radiotherapy
Radiotherapy is a treatment modality for cancer using high-energy ionizing radia-
tion. The deposition of ionizing radiation causes damage to the cells in the treated
area. This damage can result in cell dead (Rubin, 2001). The most common form
of radiotherapy is external beam irradiation with high-energy photons. Radiother-
apy aims to deliver high doses to the area containing malignant cells, while sparing
the normal tissue adjacent to this area. Models based on simple biophysical as-
sumptions have been developed to predict the tumor control probability (TCP)
(Brenner, 1993; Webb, 1993). Depending on the radiosensitivity and the volume
of clonogenic cells with a certain cell density, the TCP can be predicted for an
inhomogeneous dose distribution. These models indicate that, for the same bio-
logical effect, higher doses are needed when more clonogenic cells are present in
the target volume and when the tumor cells are relatively insensitive to radiation.
Ideally, when tumor specific data are available, this should result in dose painting,
i.e. creating a heterogeneous dose distribution within the target based on tumor
characteristics, such as radiosensitivity, clonogenic cell density and tumor hypoxia
(Ling et al., 2000).
In order to perform dose painting, radiotherapy should be image guided. Images
should provide anatomical and biological data. The advent of computed tomogra-
phy (CT) and magnetic resonance imaging (MRI) made it possible to visualize
the human anatomy. Using this anatomical information three-dimensional confor-
mal radiotherapy (3D-CRT) (Webb, 1997) could be developed. 3D-CRT is used to
avoid as much as possible irradiation of the surrounding tissue and at the same time
deliver the prescribed dose to the target. Sharper dose gradients and a better ho-
mogeneity of the dose within the target can be achieved when intensity-modulated
radiotherapy (IMRT; Webb (2001)) is applied, which is an advanced form of 3D-
CRT. Instead of using a uniform beam intensity, IMRT uses non-uniform beam
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intensities to provide more degrees of freedom for dose shaping. IMRT can also
be used for dose painting within the target volume. Positron emission tomography
(PET), nuclear magnetic resonance imaging (MRI) and spectroscopy (MRS) are
beginning to provide physical and functional information about the tumor and it
surroundings (Ling et al., 2000). The use of these imaging techniques for radiother-
apy is, however, still under development, and full dose painting is not yet possible.
For conventional radiotherapy the prescribed tumor dose is usually limited by the
dose to the surrounding critical organs. The first attempt to dose painting using
IMRT is, therefore, to escalate the dose within the gross tumor volume (GTV)
(Nederveen et al., 2001b; Mohan et al., 2000; Zelefsky et al., 2000).
Due to the sharp dose gradient between critical organs and the tumor, special
attention should be paid to the localization of the tumor when using IMRT. The
position of the tumor during the imaging process needed for the IMRT planning,
should be the same as during the actual treatment, to assure that the dose is de-
livered to the right spot. Misalignment of the patient, or organ motion, may result
in underdosage to the tumor sites and overdosage to critical organs. It is therefore
important to determine and manage geometrical uncertainties (Langen and Jones,
2001; Jaffray et al., 1999) for IMRT treatments. Ideally, the position of the target
should be visualized during the treatment.
1.2 IMRT delivery
There are several methods to delivered intensity-modulated beams. The main clin-
ically available methods use compensator filters, multi-leaf collimators (MLCs), or
tomotherapy (Webb, 1997; IMRT Collaborative Working Group, 2001). Like at
many other institutes, most linear accelerators at our department are nowadays
equipped with a MLC. The MLC consists of a set of thin blades, which can be
individually positioned, and therefore create irregularly shaped beams. There are
two approaches of IMRT delivery using MLC: the dynamic and segmental MLC
approach. Using a dynamic MLC (DMLC) technique, each pair of MLC leaves
moves during irradiation. By changing the setting of the leaf pair opening and the
speed of the leaves, it is possible to create intensity-modulated beams. The seg-
mental approach uses a series of multiple segmental fields (Fig. 1.1). The method
is also called step-and-shoot, because the beam is off when the leaves move to
the next position. By adding the individual shaped segmental fields, an intensity-
modulated beam is created. To obtain these segments, the optimized intensity
profile is divided in a discrete number of intensity levels.
The advantage of the DMLC technique is that the delivered intensity profile closely
matches the intended profile. When using segmental IMRT the intended profile is
approximated by a discrete number of segments. The conversion of the optimized
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Figure 1.1: Schematic view of segmental IMRT. Adding three in-
dividual shaped segments with the same intensity results in
a intensity-modulated field. A high gray value corresponds
with a high intensity.
intensity profile to the deliverable intensity profile is consequently important. The
quality assurance of segmental IMRT is, however, less complicated since only the
leaf positions need to be checked, whereas in DMLC both leaf position and the
speed need to be controlled (Chui et al., 2001).
1.3 Geometric uncertainties in radiotherapy
The location of the tumor is not exactly at the same position during the course of
the radiotherapy, due to geometric uncertainties, such as patient positioning er-
rors, patient movement and organ motion. Differences between the actual position
and the position during the planning, lead to misalignment between the treatment
fields and the tumor. To avoid possible reduction in TCP, the field size has to be
extended. In other words, an extra margin is added to the target volume, resulting
in a planning target volume (section 1.4.2), to ensure the that target is irradiated
with the prescribed dose (Fig. 1.2). This leads to an extra dose to the normal
tissue adjacent to the target, which can result in an increased normal tissue com-
plication probability (NTCP). The prescribed dose to the tumor is consequently
often limited by the dose to the surrounding normal tissue.
The geometric uncertainties can result in a change of the position of the tar-
get relative to other fractions (interfraction motion), and within a single fraction
(intrafraction motion). Interfraction motion can, for example, occur due to posi-
tioning errors or changes in patient anatomy such as weight loss. Organ motion
can also result in interfraction motions. In the pelvic region this is often caused
by the filling of organs such as the bladder and intestinals (Langen and Jones,
2001; Jaffray et al., 1999). Intrafraction motion is caused by periodic motions,
such as breathing and cardiac motion, or due to instant motions, such as gas mo-
tion, clenching of muscles and swallowing (Langen and Jones, 2001; Jaffray et al.,
1999).
All geometric uncertainties contribute to an error in the alignment between the
target and the treatment fields. This error can be separated in systematic and ran-
dom errors (Van Herk et al., 2000). Systematic errors are deviations between the
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PTV OAR
CTV Overlap
Figure 1.2: Schematic view of a clinical target volume (CTV),
planning target volume (PTV) and an organ at risk (OAR).
The margin taken for geometrical uncertainties causes an
overlapping area, which results a high dose area in the OAR.
average target positioning during the treatment and the planned target position.
Since the total dose of a radiotherapy treatment is the sum over all fractions, the
systematic error causes a shift in the total dose distribution. Random errors are
deviations between each fraction and occur day to day. These result in a blurring
of the total dose distribution.
1.4 Management of geometric uncertainties
1.4.1 Position verification using and EPID
In order to minimize geometric uncertainties, position verification is needed. After
verification of the position of the target, the position can be corrected using a cor-
rection protocol (Bel et al., 1993; De Boer et al., 2001). Most correction protocols
aim at minimizing the systematic errors and are off-line. Using an off-line correc-
tion protocol, the position of the target is verified after a single treatment session.
The next session the position can be corrected. The ultimate goal of position ver-
ification is, to ensure, that the target is located at the same position relative to
the treatment fields during all radiotherapy fractions. To achieve that goal online
position verification and correction should be applied. Both the random and the
systematic errors can than be removed.
Many institutes use portal imaging to measure set-up errors by applying a mega-
voltage film or an electronic portal-imaging device (EPID). Using these portal
images, the bony structures can be used as internal markers (Fig. 1.3), of which
the location can be verified with respect to their location in the reference position
(Hurkmans et al., 2001b). The reference position is thereby the position during the
imaging process used for the radiotherapy planning. The use of the bony structures
for position verification of the target is indirect, the location of the target should
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Figure 1.3: An example of a reference image (a) and a portal
image (b) taken during the treatment for head-and-neck
cancer. Beside the bony structures two markers are visible.
The location of markers is indicated by two arrows.
therefore not change relative to the bony structures. For many head-and-neck can-
cers the targets do not move relative to the bony structure, while for cancers in the
pelvic region target volumes may show motions relative to the bony structures.
Instead of the use of bony structures, radiopaque markers can be used for position
verification (Nederveen et al., 2001a; Shirato et al., 2000; Litzenberg et al., 2002).
These markers are usually made of gold. Due to their high electron density, they
can be visualized in a portal image (Fig. 1.3). The location of these markers should
be fixed relative to the target. The best place to put the markers would be the
target itself, since the location of the markers would than be the best representa-
tion of the target. This is, however, not possible for each target. Some targets can
deform during the radiotherapy course; markers within such targets are not reli-
able for position verification. Although the use of implanted markers is invasive, it
has several advantages. When the target can move relative to the bony structures,
the marker, in case its location is fixed to the target, better represents the target
location. In that case markers can be used to remove the systematic errors, while
using bony structures this is not possible. Another benefit of the use of markers is
that the determination is straightforward in images and a small number of monitor
units is sufficient to obtain a suitable portal image. This facilitates automatically
detection of the markers within the portal images. Marker-based position verifica-
tion can therefore also be used for measuring intrafraction motions. Furthermore,
markers can be detected in small fields as used for IMRT treatments, while the
use of bony structures is difficult when only small fields are used.
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1.4.2 PTV-CTV margin
The clinical target volume (CTV) should be treated adequately in order to achieve
the aim of radical therapy (ICRU Report No. 62, 1999). The CTV is a tissue vol-
ume that contains the gross tumor volume (GTV) and/or subclinical malignant
disease that must be eliminated (ICRU Report No. 62, 1999). Due to the geometric
uncertainties in the location of the CTV relative to the treatment field, a margin
should be added to the CTV (Fig. 1.2). If no margins are added to the CTV some
tissue may, for part of the treatment move out of the beam. The resulting vol-
ume is the planning target volume (PTV). This is a geometrical concept used for
treatment planning, and it is defined to select appropriate beam sizes and beam
arrangements, to ensure that the prescribed dose is actually delivered to the CTV
(ICRU Report No. 62, 1999).
Both the random (σ) and systematic (Σ) positioning errors contribute to the mar-
gin between the CTV and the PTV. For a margin that ensures 95 % minimum
dose for 90 % of the patients the following recipe was derived by Van Herk et al.
(2000) when perfect conformation is assumed in 3D and 2D respectively:
Margin(3D) = 2.5Σ + 0.7σ (1.1)
Margin(2D) = 2.15Σ + 0.7σ (1.2)
A similar recipe was derived by Stroom et al. (1999) (equation 1.3). The criterion
to derive the recipe was that on average more than 99% of the CTV should at
least get 95% of the dose.
Margin = 2Σ + 0.7σ (1.3)
The differences between the recipes might be due to the fact that different criteri-
ons were used. Both recipes demonstrate the large contribution of the systematic
error to the margin. Using position verification to minimize the geometric un-
certainties and thus reduce the margin, the main effort should be to reduce the
systematic error. This can be achieved using marker-based position verification.
The benefit of the use of markers is that it can be used as a direct verification of
the target, since these can be placed inside the target (Nederveen et al., 2001a).
Systematic errors can therefore be removed for targets loosely attached to the
bony anatomy.
1.5 Clinical applications of IMRT
1.5.1 IMRT for breast cancer
Many patients have been successfully treated with breast conserving radiotherapy
(Fisher et al., 1989; van Dongen et al., 1992; Morris et al., 1997). The gross tumor
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is thereby surgical removed and the entire breast is treated with radiotherapy in
order to control the subclinical disease. The aim for breast conserving radiotherapy
is to deliver a homogeneous dose of 50 Gy (2Gy/fraction;5 times weekly) to the
breast, which can be followed by a small boost dose of 14-20 Gy (2Gy/fraction;5
times weekly) to the tumor bed (Bartelink et al., 2001). The advent of CT made
it possible to visualize the anatomy of the breast and to calculate and analyze the
three-dimensional dose distribution. The dose homogeneity of the breast has been
studied by several groups (Buchholz et al., 1997; Carruthers et al., 1999; Cheng
et al., 1994; Neal et al., 1995; Solin et al., 1991). Using conventional techniques,
such as wedged fields, it is not always possible to achieve a homogeneous dose
distribution due to the complex geometry of the breast. The inhomogeneities typ-
ically occur at the entry points, the most caudal en cranial part of the treated
volume and the nipple. An inhomogeneous dose is believed to be a contributing
factor to the cosmetic result after radiotherapy (Moody et al., 1994), because poor
cosmesis occurs more often in patients with large breasts (Gray et al., 1991; Moody
et al., 1994; Vrieling et al., 2000) and the dose inhomogeneity of these patients is
larger compared to patients with smaller breasts (Buchholz et al., 1997; Cheng
et al., 1994; Neal et al., 1995). The dose homogeneity can be improved by beam
intensity modulation. Beside the ability to improve the dose homogeneity, IMRT
might be used to decrease the dose to the lung and the heart. This is important
since side effects due to irradiation of the breast, such as ischemic heart disease
(Gyenes et al., 1998) and radiation pneumonitis (Kwa et al., 1998), may occur.
Beside setup errors, organ motion due to breathing will contribute to the margin
taken for geometrical uncertainties. The intra- and interfraction reproducibility of
tangential breast irradiation has been determined using an EPID (Fein et al., 1996;
Lirette et al., 1995; van Tienhoven et al., 1991). One of the parameters studied
is the central lung distance (CLD), which is the distance from the posterior field
margin to the inner chest wall along the horizontal axis of the field. For normal
respiratory function, the standard deviation of the intrafraction motion is reported
1-2 mm. The standard deviation of the reported random errors is higher, 2 - 4.4
mm, and the variations in the systematic error are 3-4 mm.
1.5.2 IMRT for Head & Neck cancer
Oropharyngeal cancer
For the treatment of cancers in the head-and-neck region different treatment strate-
gies are used, such as surgery, radiotherapy, chemotherapy or combinations of
these modalities. Almost all early oropharyngeal tumors (T1 and T2) are treated
with radiation therapy alone. The aim at our department is to deliver a dose
of 46-50 Gy (2Gy/fraction;5 times weekly) to the microscopic disease and 70 Gy
(2Gy/fraction;5 times weekly) to the macroscopic disease (primary tumor and pos-
itive lymph nodes). The dose to the target is often limited by the maximum dose
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to critical organs adjacent to the targets, such as the spinal cord and brain (Emami
et al., 1991). Another severe complication is xerostomia, caused by irradiation of
the salivary glands (Chao et al., 2001; Eisbruch et al., 1999; Roesink et al., 2001).
The use of CT made it possible to delineate all target volumes and organs at risk.
A simple form of dose painting can be created, when different dose levels are as-
signed to the individual volumes. The primary tumor and the lymph nodes will
thereby receive a different dose, while at the same time the dose to the organs at
risk is minimized. In order to develop such a technique, IMRT can be used. With
IMRT the different dose levels to the primary tumor and the lymph nodes can be
delivered simultaneously. However, other fractionation strategies should than be
developed compared to conventionally used (Mohan et al., 2000). Using IMRT it
is even possible to deliver a higher dose than conventionally given, in other words
to escalate the dose, while sparing surrounding normal tissues. There are several
studies indicating that dose escalation might be useful. For oropharyngeal cancer
local-regional recurrences after radiotherapy occur most frequently at the site of
the original tumor (Pigott et al., 1995). It has also been reported that when using
conformal or segmental IMRT most recurrences occurred within the areas judged
to be of high risk at the time of the radiotherapy planning (Dawson et al., 2000a).
Furthermore it has been shown that a higher total dose and reduction of the treat-
ment time could improve the local control for oropharyngeal tumors (Maciejewski
et al., 1989; Withers et al., 1995b).
In order to deliver a high conformal dose distribution and prevent high doses
to critical structures, accurate patient positioning is essential. Usually patients
treated for head-and-neck cancer are immobilized using a thermoplastic mask.
Position verification is performed with a megavoltage film or EPID, where the
location of the bony structures within the treatment fields is determined. The
random and the systematic error amount to approximately 2 mm (1 standard de-
viation) (Hurkmans et al., 2001b). Intrafraction displacements have not yet been
quantified for patients with head-and-neck cancer.
Preservation of the salivary glands
During radiotherapy of head-and-neck cancers, the parotid gland is often exposed
to radiation, which can cause severe reduction of salivary flow and change in
salivary composition. This may result in xerostomia, difficulties in mastication
and speech, changes of taste, increased risk of carries and oral infections, chronic
esophagitis and altered nutrition (Hamlet et al., 1997; Mandel, 1987; Vissink et al.,
1988; Wright, 1987). These severe side effects have a negative impact on the quality
of life of the patient (De Graeff et al., 1999; Huguenin et al., 1999). Although with
IMRT highly conformal plans can be achieved, there is still a significant dose to the
parotid gland because the lymph nodes are located adjacent to the parotid glands.
The PTV of the lymph nodes will therefore overlap with the parotid glands. When
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no reduction of the TCP is allowed, this part of the parotid glands should receive
the prescribed dose.
1.6 Outline of this thesis
In chapter 2 the development of a segmental IMRT technique using 3D geometrical
information for tangential breast irradiation is presented. The IMRT technique is
applied to achieve a homogeneous dose distribution through the entire breast. The
shape of the individual segments was obtained from an equivalent path length map
of the irradiated volume.
In chapter 3 segmental IMRT is applied for the treatment of oropharyngeal cancer,
which is a more complex case than the breast. Different dose levels are delivered
to the primary tumor, the CTV of the primary tumor and the CTV of the lymph
nodes, while the dose to surrounding organs at risk is minimized. This can be
considered a simple form of dose painting. The relation between the quality of the
treatment and the number of beams in combination with the number of segments is
investigated. This information will be used for developing an efficient and reliable
segmental IMRT technique.
Chapter 4 deals with the dose to the parotid gland. Using the segmental IMRT
technique presented in the previous chapter, the dose to the parotid gland is re-
duced without compromising the dose to the targets. Due to the margin taken for
geometrical uncertainties, the PTVs will partially overlap with the parotid glands.
This causes a high dose area in the parotid glands. The effect of reduction of
positioning margins is presented in this chapter.
In chapter 5 the feasibility of the use of implanted gold markers for position ver-
ification in the head-and-neck region is investigated using and EPID. Accurate
position verification is needed to deliver the dose at the right spot, particularly
for highly conformal plans created with IMRT. Markers were implanted in ten
patients and the toxicity and the reliability of marker-based position verification
was studied.
In chapter 6 intrafraction motions in the larynx are studied. Although most struc-
tures in the head-and-neck are relatively immobile, the larynx is a rather mo-
bile organ. Due to the high image quality of the EPID, the displacements of the
anatomical structures could be determined for 10 patients during radiotherapy.
A general discussion is presented in chapter 7. Imaging in radiotherapy, IMRT for
breast cancer and IMRT for oropharyngeal cancer will be discussed separately.

Chapter 2
An improved breast irradiation technique using
three-dimensional geometrical information and
intensity modulation
This chapter has been published as
B. van Asselen, C.P.J. Raaijmakers, P. Hofman and J.J.W. Lagendijk 2003 An
improved breast irradiation technique using three-dimensional geometrical infor-
mation and intensity modulation Radiotherapy and Oncology 58 341–347
Abstract
Background and purpose: In spite of the complex geometry of the breast, treatment plan-
ning for tangential breast irradiation is conventionally performed using two-dimensional
patient anatomy information. The purpose of this work was to develop a new technique
which takes the three-dimensional (3D) patient geometry into account.
Materials and methods: An intensity-modulated radiotherapy (IMRT) technique was de-
veloped based on the division of the tangential fields in four multi-leaf collimator (MLC)
shaped segments. The shape of these segments was obtained from an equivalent path
length map of the irradiated volume. Approximately 88 % of the dose was delivered by
two open fields covering the whole treated volume. Dose calculations for the IMRT tech-
nique and the conventional technique were performed for five patients, using computer
tomography (CT) data and a 3D calculation algorithm. A planning target volume (PTV)
and ispsilateral lung volume were delineated in these CT data.
Results: All patients showed similar equivalent path length patterns. Analysis of the dose
distribution showed an improved dose distribution using the IMRT technique. The dose
inhomogeneity in the PTV was 9.0 % (range 6.4–11.4 %) for the conventional and 7.6
% (range 6.5–10.3 %) for the IMRT technique. The mean lung dose was reduced for the
IMRT technique by approximately 10 % compared with the conventional technique.
Conclusion: A new breast irradiation technique has been developed which improves the
dose homogeneity within the planning target volume and reduces the dose to the lung.
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Furthermore, the IMRT technique creates the possibility to improve the field matching
in case of multiple field irradiations of the breast and lymph nodes.
2.1 Introduction
Breast conserving radiotherapy is a commonly used treatment for breast cancer.
In spite of the complex geometry of the breast, the treatment planning of tan-
gential breast irradiation is conventionally performed using a two dimensional
planning system and a two-dimensional (2D) contour of the breast and the lung
in the central plane. Optimization of the dose distribution in this plane is per-
formed by manual interactive optimisation of the wedge angle that compensates
for the varying contour of the breast. The 3D dose distribution for the tangential
breast irradiation has been analyzed using CT data in several studies (Buchholz
et al., 1997; Carruthers et al., 1999; Cheng et al., 1994; Hong et al., 1999; Solin
et al., 1991; Neal et al., 1995). These studies demonstrated relatively large dose
inhomogeneities inside the target volume in some patients. The largest dose inho-
mogeneities occur particularly in patients with large breast sizes (Buchholz et al.,
1997; Moody et al., 1994; Neal et al., 1995).
The dose homogeneity in the breast can be improved by beam intensity modula-
tion (Carruthers et al., 1999; Hong et al., 1999; Evans et al., 1998; Lo et al., 2000).
The modulated beams are generally delivered by a physical compensator or by a
dynamic multi-leaf collimator (DMLC). The use of physical compensators is, how-
ever, time consuming and the use of DMLC requires extensive quality assurance.
In our institution therefore a “step and shoot” method is preferred. Since breast
irradiation is the most commonly applied technique in our institution the new
technique should be straightforward, reliable and efficient. One group reported a
method using MLC-shaped wedged fields to improve the dose inhomogeneity (Lo
et al., 2000).
In order to obtain complete target coverage with tangential fields, it is unavoidable
to irradiate part of the ipsilateral lung. The dose to the lung should be as low as
possible, in order to prevent radiation pneumonitis (Kwa et al., 1998) and late
fibrosis.
In our institution, a standard technique is used for all tangential breast irradiations
(Lagendijk and Hofman, 1992). Patients are positioned on a wedged breast-board
in order to obtain a vertical match plane between the tangential fields and the
supraclavicular and axillary fields in case of multiple field irradiations. Patients
lying on a breast-board are difficult to position inside a CT scanner due to the
limited size of the bore of the scanner.
If a parasternal field is applied, the match of the tangential fields to the paraster-
nal field is performed in the central plane. Due to the curvature of the thorax,
however, the optimal match is not maintained along the whole length of the field
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Figure 2.1: The tangential fields are shaped using the multi-leaf
collimator, by following the curvature of the thorax. In this
way the cranial vertical match plane is maintained without
using the breast board.
and using a rectangular field setting, under-dosage or over-dosage in the match
region is almost unavoidable.
It was the purpose of our work to develop a new technique for tangential breast ir-
radiation which avoids the above mentioned problems. This technique should fulfil
the following criteria: (1) improve the dose homogeneity; (2) maintain a vertical
match plane between the tangential fields and the supraclavicular and axial fields
without using a breast-board in order to facilitate the positioning of patients in a
CT scanner; (3) have the possibility to match the parasternal field to the tangen-
tial fields with the same overlap over the whole length of the field. A new improved
breast irradiation technique, developed at our institution, will be described and
analyzed in this paper. The parasternal field and supraclavicular and axillary fields
are not taken into account in our analysis of the dose distribution.
2.2 Methods and Materials
2.2.1 MLC field shaping
Positioning of the patient without breast board, while avoiding excessive lung
irradiation and maintaining a vertical match plane between the tangential fields
and the supraclavicular and axillary fields, demands the appliance of complicated
shielding techniques (Lebesque, 1986) or the combination of collimator and couch
rotations (CaseBow, 1984; Lagendijk and Hofman, 1992). A vertical match plane
can, however, also be obtained by applying MLC field shaping (Fig. 2.1). Using
the MLC in this way furthermore creates the possibility of shaping the medial
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parasternal entrance of the tangential field in order to match it dosimetrically with
the parasternal field along the whole length of the field. On the other hand the use
of MLC shaping of the tangential fields implies that the wedges cannot be used
to optimize the dose distribution since in our linear accelerators (Elekta Oncology
Systems, UK) the wedge direction is perpendicular to the leaf direction. Therefore,
an intensity-modulated radiotherapy (IMRT) technique had to be developed using
MLC field shaping only. The use of MLC field shaping and the 3D optimization
of the dose distribution implies further that a 3D CT data set of the patient has
to be available.
2.2.2 Volumes of interest
Five patients underwent a planning CT scan. Due to the limited size of the bore of
the CT-scanner in combination with the treatment set-up, large patients or large
breast board angles could not be included. After positioning, conventional field
settings were defined by a radiation oncologist. Although the aim of this work
was to abandon the breast board, the patients were scanned in the conventional
treatment position using the breast-board in order to compare a new technique
with the conventional technique. The patients were positioned according to the
local protocol i.e. supine with their hands upon their head (Lagendijk and Hof-
man, 1992). Next, the treatment field was marked by tiny lead wires, in order to
visualise the conventionally applied field borders in the CT data. CT scanning
was performed with slices spaced at a 5 mm interval, from the cranial side of the
acromio-clavicular joint till 2 cm caudal from the submammary fold. In order to
analyze the 3D dose distribution, a clinical target volume (CTV, ICRU Report
No. 50 (1993)) and lung volume were delineated by the physician. The planning
target volume (PTV) was obtained by adding a 1-cm margin to the CTV, except
for the skin side of the CTV where the margin was limited to the subcutaneous
layer. In order to analyse the dose to the lung the ipsilateral lung volume was
drawn. The volumes (Table 2.1) of the organs at risk and the target volumes were
determined by a random sampling technique (PLATO EVAL 2.5, Nucletron Ltd).
The irradiated lung volume was defined as the lung volume receiving a dose equal
or greater than 50% of the prescribed dose for the conventional plan. Besides the
above-mentioned volumes, the patient separation in the central plane is shown in
Table 2.1. The patient separation is defined as the distance between the lateral
and medial entrance point of the posterior border of the treatment field.
2.2.3 Conventional technique
The beam parameters of the tangential beams are conventionally derived from
X-ray guided localization. The angle between these beams is chosen in such way
that the posterior borders of the lateral and medial fields are coplanar, in order
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Table 2.1: The clinical target volume (CTV), planning target vol-
ume (PTV), the patient separation in the central plane, the
total volume of the ipsilateral lung and irradiated lung vol-
ume (ILV)a.
Patient CTV PTV Patient separation Lung volume ILV
[cm3] [cm3] [cm] [cm3] [cm3]
A 257 419 17.2 1556 97
B 71 159 18.2 1974 263
C 233 402 18.0 1159 107
D 140 253 18.0 2008 243
E 943 1283 23.0 1191 405
a The uncertainty in the calculated volumes is approximately 0.5% (1 SD).
to prevent extra dose to the lung due to the divergence of the beams. In order
to apply our standard technique to the CT data set, the posterior borders of
the fields were matched with the standard medial and lateral entrance point as
displayed by the lead wires. Next, the conventional beam settings were compared
with the beam settings derived from the CT data. This comparison resulted in
some cases in adjustment of the field settings (< 5mm) to obtain a better coverage
of the PTV. For this study it is assumed that the CT data are preferred over
the conventional localization data. After adjustment, the 3D dose distribution was
calculated using a 3D planning system (PLATO RTS version 2.2, Nucletron Ltd),
with a grid space between 3.0 and 3.5 mm. The planning system uses a convolution
based pencil-beam model (Bortfeld et al., 1993), with the equivalent tissue-air
ratio (ETAR) method (Sontag and Cunningham, 1978) for tissue inhomogeneity
corrections. The energy of the beams was chosen to be 6 MV for four patients. For
patient E, with the largest breast, 10-MV beams were used. The wedge angles and
the weights of the two tangential beams were optimized to obtain a homogeneous
dose distribution in the central plane. The dose distribution was normalized at the
isocentre in the central plane. The prescribed dose was 50 Gy at the isocentre.
2.2.4 IMRT technique
The dose distribution of a conventional plan usually shows three high dose areas
in the central plane, namely at the medial and lateral side of the lung and near
the apex of the breast. Conventionally, optimizing of the dose distribution is done
by equalizing the dose in these three areas. In this way however, the PTV obtains
a relatively high dose at the three high dose areas and a relatively high dose is
delivered to the lung itself. The high-dose areas “behind” the lung result from
the relatively short equivalent path length through lung tissue compared with sur-
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rounding tissue. Although the aim was to improve the 3D dose distribution, the
first attempt was to improve the dose distribution in the central plane. The devel-
opment of the IMRT technique was started by applying an open field to the part
of the irradiated volume which contains lung tissue, while the other part of the
breast is treated using a wedged field. The dose distribution in the central plane
improved using this approach. The wedge, however, had to be abandoned and was
therefore mimicked by an intensity-modulated field. The dose distribution in other
planes did not improve substantially using the combination of an open part and
wedged part of the treatment field. In order to improve the dose distribution in
off-axes planes a systematic method had to be developed to deduce the various
intensity levels, and thus the shape of the MLC field settings, from the patient
geometry. Eventually a method was developed based on the division of the irradi-
ated volume into segments with a similar equivalent path length.
In first approximation, the equivalent path length along a ray line from the focus
through the breast is proportional to the dose delivered at a specific depth. In
the case of two opposed tangential fields, ray lines with a similar equivalent path
length should approximately have the same beam intensity to obtain a homoge-
neous dose distribution. To test this approach, 2D equivalent path length maps
(EPMs) were generated from the CT data set using software developed in our in-
stitution. The equivalent path lengths, obtained from ray tracing from the focus of
the beam through the CT data set, were projected on a plane perpendicular to the
beam axes (Fig. 2.2). The equivalent path length through a voxel was calculated
by multiplying the ray length through the voxel by its relative electron density.
The total path length was obtained by a summation of the equivalent path lengths
of all voxels a ray passes. The relative electron density was determined using a ta-
ble (Schneider et al., 1996; Kno¨o¨s et al., 1986) that transfers the Hounsfield units,
obtained from the CT data set, to relative electron density. The field size, isocentre
and gantry angle used to calculated the EPMs were obtained from the adjusted
conventional beam settings.
The translation of such an EPM into optimal MLC field settings and intensity lev-
els is a complex problem. The distance between the minimum and the maximum
path length, derived from the EPM, was divided in four discrete, equally spaced
intervals. Each interval covers a range of path lengths. The resulting map (Fig.
2.3) is used to obtain the MLC settings. The MLC settings deduced from this map
were entered into the 3D planning system by hand enclosing each level with the
leafs, except for the largest segment, which was a rectangular open field enclosing
the total irradiated volume. In order to simplify the MLC settings, leaf positions
where the gap between two opposite leafs was smaller then approximately 10 mm,
were not taken into account. In this way a total number of four MLC segments
could be obtained for all patients (Fig. 2.4). The 3D dose distribution was calcu-
lated using the same adjusted field settings as in the conventional plan. Weighting
of the various segments was performed at a point at the centre of the smallest seg-
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Figure 2.2: An equivalent path length map for tangential breast
irradiation (patient A). The left and right side in the figure
are cranial and caudal, respectively.
Figure 2.3: The equivalent path length map for the same breast
as in Fig. 2.2 divided into four discrete path length intervals.
ment corresponding to the greatest equivalent path length (Fig.2.4). The largest
segment delivers most dose to the breast while the other segments are used to ob-
tain a homogeneous dose distribution. Analyses of the dose distribution calculated
for two open beams, in off-axes planes showed that the variation in dose was ap-
proximately 10-15 %. For our IMRT technique we have chosen that approximately
88 % of the dose to the weighting point was delivered by the largest segments. In
order to standardize the weighting procedure, the remaining 12 % were equally
divided over the other segments. Finally the weights of the largest segments, the
rectangular open fields, were used to improve the homogeneity in the lateral me-
dial and medial lateral direction. The ratio between the dose delivered by these
two rectangular segments and the remaining segments was thereby maintained.
Normalization and prescription (100 % = 50 Gy) of the plans was performed at
the isocentre in the central plane.
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Figure 2.4: The four multi-leaf collimator settings for each inten-
sity level as deduced for the equivalent path length map in
Fig. 2.3. The first segment includes the areas 1-4, the sec-
ond segment the areas 2-4, the third segment the areas 3-4
and the fourth segment area 4. W is the weighting point.
2.2.5 Analysis
After the calculation of the 3D dose distribution, isodose contours were displayed
in several planes. Furthermore dose-volume histograms (DVHs) of the conventional
and IMRT plan were calculated.
Quantification of the dose distribution was done by calculating D95−5%. Using the
DVH two dose values ( D95% and D5% ) were extracted; 95% of the PTV receives
a dose equal or more than D95% and 5% of the PTV receives a dose equal or more
than D5%. D95−5% is defined as the difference between D95% and D5% . These
doses are indicators of the low- and high-dose regions in the PTV, respectively.
Consequently, D95−5% indicates the dose range for 90 % of the volume. An advan-
tage of this quantification method is its independence of a normalisation procedure
and its potentiality for easy comparison of the dose distributions between patients
from different institutes.
In order to analyze the dose to the lung, the average dose to the ipsilateral lung
was calculated using a random sampling technique (PLATO EVAL 2.5, Nucletron
Ltd).
2.3 Results
2.3.1 Equivalent path length maps
EPMs calculated for the five patients all showed patterns similar to Fig. 2.2. The
maximum path length was 19.3, 18.7, 24.6, 18.5 and 24.1 cm for patient A to
E, respectively. The equivalent path length changes gradually over the treated
volume. Starting from the skin side, the path length increases until the region is
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(a)
(b)
Figure 2.5: The dose distribution in the central plane for the
conventional (a) and the intensity modulated radiotherapy
treatment (b) technique (patient A). The PTV is delineated
by the dashed line.
reached were lung tissue is involved. Due to the low relative electron density of the
lung tissue compared with the breast tissue, the equivalent path length through
the lung is smaller than that of the adjacent breast tissue. For all patients the path
length increased towards the cranial part of the treated volume. Only the patient
with the largest breast also showed an area with a large path length in the caudal
region.
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(a)
(b)
Figure 2.6: The isodose contours displayed in an oblique sagittal
plane, calculated for the conventional (a) and the intensity
modulated radiotherapy treatment (b) technique (patient
A). The plane is perpendicular to the posterior field border
of the treatment fields and through the isocenter. The lung
tissue is indicated by the gray region. The left and right side
in the figure are cranial and caudal, respectively. The PTV
is delineated by the dashed line.
Table 2.2: D95−5% of 5 patients calculated for the conventional
(Conv) and the intensity modulated radiotherapy (IMRT)
technique (100 % = 50 Gy).
Patient Conv IMRT Ratio
[%] [%] IMRTConv
A 10.5 7.0 0.70
B 8.1 6.6 0.81
C 8.8 7.8 0.87
D 6.4 6.5 1.02
E 11.4 10.3 0.90
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Figure 2.7: Dose-volume histograms calculated for five patients
for the conventional (solid line) and intensity modulated
radiotherapy (dashed line) treatment technique.
2.3.2 Dose analysis
The dose distributions displayed by isodose contours in the central plane, show
an improved dose distribution for the IMRT technique compared with the conven-
tional technique (Fig. 2.5). For the same patient the isodose contours are displayed
in an oblique sagittal plane (Fig. 2.6).
The differential DVHs showed improved dose homogeneity for the IMRT technique
compared with the conventional technique (Fig. 2.7).
Compared to the conventional technique the D95−5% decreased in four cases for
the IMRT technique with a maximum of 29 % (Table 2.2). However, in one case,
the D95−5% increased by 2 %. The D95−5% of this patient for the conventional plan
is, however, already small compared with that of the other patients and could not
be improved. In general, the results show that the dose homogeneity of the IMRT
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Table 2.3: Average lung dose of the ipsilateral lung calculated
for the conventional (Conv) and the intensity modulated
radiotherapy (IMRT) technique.
Patient Conv IMRT Ratio
[Gy] [Gy] IMRTConv
A 4.9 4.1 0.84
B 8.3 7.4 0.89
C 6.1 5.3 0.87
D 7.4 6.6 0.89
E 18.5 17 0.92
plans is the same or better than that of the conventional plan.
Using the IMRT technique, the average dose to the ipsilateral lung decreased with
a mean value of 11.8 % (range 8 - 16%) compared with the conventional technique
(Table 2.3).
2.4 Discussion
In this work an IMRT technique is presented based on the division of the treat-
ment field in segments with a similar equivalent path length through the breast.
Comparison of the DVHs and isodose contours of the IMRT technique with those
of our conventional treatment technique showed that the homogeneity of the dose
was improved using the IMRT technique.
Part of the low dose region seen in the DVHs is unavoidable, since this is caused
by the build-up of the dose in the PTV near the skin. This build-up ensures an
acceptable cosmetic outcome of the breast and should therefore be maintained.
Only when a tumor is located near the skin (< 1.5 cm) bolus material is placed
to increase the dose in that region of the PTV. There was no bolus material used
for the patients analyzed in this work.
In order to quantify the dose distribution, the dose difference between 95 and 5
% (D95−5%) of the volume was measured. An advantage of this method is that
it is independent of normalization procedures used in different institutions and
facilitates comparison with different institutions. The average value of D95−5% for
the conventional plan was 9.2 % (range 6.4 – 11.4 %) and for the IMRT technique
7.6 % (range 6.5 – 10.3 %). The dose distribution for the conventional plan of pa-
tient D was the most homogeneous one and could probably not be improved. The
most inhomogeneous dose distribution was obtained in the patient with the largest
breast. For such patients the use of more intensity levels or optimized weighting
of the segments, might result in a further increase of the dose homogeneity.
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The inhomogeneity of the dose distribution for tangential breast cancer has been
studied by several groups (Buchholz et al., 1997; Carruthers et al., 1999; Cheng
et al., 1994; Hong et al., 1999; Solin et al., 1991; Neal et al., 1995) using CT data.
It is, however, rather difficult to compare our results with those of other studies
because different methods are used to analyze the dose distribution. The methods
used by Solin et al. (1991) are the closest to our study. They determined the iso-
dose which covers 5 % and 95 % of the volume for a standard wedge plan using
CT information and inhomogeneity corrections. On the analogy of this study this
would mean a D95−5% of approximately 15 %. Analyzing 17 patients Carruthers
et al. (1999) showed a heterogeneity of 12 % (range 8 - 17 %) for a wedged plan
and 5 % (range 4 - 7 %) for a IMRT technique using compensators. Their hetero-
geneity is defined by the difference between the maximum dose and the isodose
that just covers the target volume. Evans et al. (1998) calculated the volume per-
centage which received a dose outside the range of 95-105 % of the prescribed dose.
They determined an average of 13.2 % for a technique using wedged tangential
fields and 3 % for their IMRT technique using physical compensators. Pseudo-CT
scans (Evans et al., 1995) were used for their analysis. Using inverse planning to
generate intensity-modulated plans, Hong et al. (1999) showed an improved dose
homogeneity in the PTV, especially in the superior and inferior regions. Lo et al.
(2000) developed a technique using MLC shaped wedged tangential fields to im-
prove the dose distribution in the breast. A systematic procedure to derive the
MLC shaped segments is, however, not presented.
The inhomogeneity of the dose distribution determined for the conventional tech-
nique in this work is relatively small. Nevertheless, we showed that we could repro-
duce or improve the dose homogeneity using our IMRT technique. Furthermore,
when a larger inhomogeneity is observed in a patient, tools are now available to
improve this. The range of the PTV of the patients we analyzed is large (159 –
1283 cm3). More patients should, however, be analyzed to study our IMRT tech-
nique. It should also be noted that, although the target volume was drawn by
an experienced physician, there are no standard procedures for delineating a tar-
get volume. This could cause inter-physician variability in delineating the target
volume. Dose analysis of the conventional target volume, the tissue within 1 cm
of the field borders and with exclusion of the lung volume, showed similar dose
distributions as that of the PTV.
Dose analysis of the ipsilateral lung showed that the average dose decreased for
all patients (range 8 - 16 %). Consequently, the probability for inducing radiation
pneumonitis was decreased for the IMRT technique (Kwa et al., 1998). Reducing
the myocardial dose was not the aim of this work. However, we used the conven-
tional field set-up and reduced the dose to the lung. Therefore, the myocardial
dose for the IMRT technique will probably be less or equal compared to the con-
ventional technique. The dose to the contra-lateral breast will probably be smaller
for the IMRT technique since no wedge is used, resulting in a fewer number of
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monitor units then conventionally given.
In this work the patients were positioned supine on a breast board following
our conventional treatment technique (Lagendijk and Hofman, 1992). The breast
board, however, is used to obtain a flat sternum, which is not necessarily needed
using MLC field shaping, since the MLC can be used to follow the curvature of
the thorax. An advantage of leaving the breast board concept, would be that CT
scanning of patients becomes easier. The IMRT technique we described will be
tested using CT scans of patients treated without a breast board. The irradiated
volume of the lung should thereby be compared between these different treatment
positions. Using our IMRT technique it is possible to maintain the axillary and
supraclavicular field match, with and without the breast board. The conventional
field set-up (Lagendijk and Hofman, 1992) can therefore be used when these fields
are necessary. The match between the tangential fields and the parasternal field
can be improved using the new technique, because the leaves are positioned in the
anterior-posterior direction. The shape of the posterior field border can be adjusted
to obtain a uniform dose distribution along the match line of the parasternal and
the medial tangential field. This aspect will be analyzed in the near future.
Several other aspects of the IMRT technique need to be further investigated. The
deduction of the MLC settings from the EPM was done in this study by eye,
ignoring the relatively small areas with slightly different path lengths. Currently
software is being developed to generated MLC settings automatically from the
EPM. The number of intensity levels was chosen to be four for all patients, which
is similar to others groups (Donovan et al., 2000; Tyburski et al., 1999). This ap-
proach worked well for the patients we studied. We made the choice for a minimum
number of intensity levels to assure a clinically practical technique. Four levels is
probably close to the minimum when the dose distribution in off-axis planes is
taken into account. The number of intensity levels could, however, be optimised,
since the number of intensity levels will influence the homogeneity of the dose dis-
tribution. Especially for patients with large breasts the use of more intensity levels
will probably result in an increased dose homogeneity. The relation between the
optimum number of intensity levels and the geometry of the breast will be further
analyzed, since the largest inhomogeneities are usually observed in patients with
large breasts. The proportion of the various segments (approximately 88 % for the
largest segment and 12 % for the remaining three smaller segments) was based on
a first approximation and not on geometrical patient information alone. Although
the proportions of the various segments used in this work gave good results, our
choice of segment weighting could influence the dose homogeneity and will be fur-
ther analyzed.
The presented technique currently consumes more time than conventional treat-
ment planning. However, most steps can be easily automated. The time needed
for treatment planning will therefore eventually be equal or less than needed for
the conventional technique. CT scanning of the patient will than be the only extra
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workload. Other practical aspects of the IMRT technique, such as the matching
of the tangential field with the parasternal field, are subjects of further research.
Film dosimetry using an anthropomorphic breast phantom will be used to verify
the dose distribution obtained using the described IMRT technique.
When various problems are solved a true inverse planning method will be devel-
oped for tangential breast irradiation, i.e. a treatment planning based solely on
geometrical information.
2.4.1 Conclusion
An IMRT technique has been developed based on the division of the treatment field
in four segments with similar equivalent path lengths through the breast. Anal-
ysis of the dose distribution obtained with this technique showed a better, more
homogeneous dose distribution compared with that obtained with conventional
tangential breast irradiation. The average dose to the ipsilateral lung is reduced
using the IMRT technique by approximately 10 % compared with the conventional
technique. Furthermore this new technique has the possibility to improve the field
match between the tangential fields and the parasternal field, while maintaining
the field match between the tangential fields and the axillary and supraclavicular
fields.
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Abstract
Purpose: To develop a segmental intensity-modulated radiotherapy (IMRT) technique for
the treatment of oropharyngeal cancer.
Methods and Materials: Eight patients previously treated for oropharyngeal cancer were
replanned with segmental IMRT. The dose distribution was optimized using beam geome-
tries consisting of 3, 5, 7 and 9 equiangular beams. The optimization procedure resulted
in a theoretical fluence for each beam. In order to vary the number of segments, the opti-
mized fluence was divided in four different equidistant levels. The final dose distribution
was calculated using clinically deliverable segments obtained from optimized fluence.
Results: For our segmental IMRT technique the dose homogeneity within the target vol-
umes improved when the total number of segments increased and reached a saturation
level at approximately 150 segments. Seven beams were sufficient to achieve the satura-
tion level for dose homogeneity. The mean dose to the parotid glands depended on the
beam geometry and tumor location and did not depend on the number of segments. On
average the mean dose to the contralateral parotid gland was 35.7 Gy (27.1 - 39.9 Gy)
for all seven beam plans.
Conclusion: Seven beams are sufficient to achieve an acceptable dose homogeneity within
the target volumes and significant parotid sparing. These results will be used to introduce
IMRT in routine clinical practice.
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3.1 Introduction
Due to the complex geometry of the various target volumes and organs at risk, it
is useful to apply intensity-modulated radiotherapy (IMRT) for the treatment of
oropharyngeal cancers. Most studies concerning the IMRT treatment of oropha-
ryngeal cancers (Vineberg et al., 2002; Chao et al., 2000; Wu et al., 2000; van
Asselen et al., 2002), focus on the sparing of the parotid glands, since xerostomia
is a severe complication of irradiation of the head-and-neck region (Roesink et al.,
2001; Eisbruch et al., 1999). Besides the ability to deliver highly conformal dose
distributions, IMRT can be used to deliver different dose levels to different target
volumes at the same time, such as the tumor and the electively treated lymph
nodes. This ability can also be used to improve the tumor control probability
(TCP) by increasing the dose to the target volume, without increasing the dose
to the surrounding tissues (Nederveen et al., 2001b; Wu et al., 2000; Mohan et al.,
2000).
The number of beams, the beam orientations and the number of segments, when
using a segmental MLC delivery technique, are important parameters for the op-
timization process of an IMRT plan and result in a vast amount of degrees of
freedom for the optimization process.
Optimization of beam orientation for IMRT has been studied by several groups
(Pugachev et al., 2001; Rowbottom et al., 2001; So¨derstro¨m and Brahme, 1995;
Stein et al., 1997). In most of these studies, beam orientation optimization re-
sulted in improved dose distributions, when a small number of beams (<5) was
applied (Rowbottom et al., 2001; So¨derstro¨m and Brahme, 1995; Stein et al., 1997).
The clinical introduction of beam orientation optimization is, however, hampered
by the long computation times(Pugachev et al., 2001; Rowbottom et al., 2001).
Consequently, IMRT if often clinically introduced using a fixed beam geometry
(Nederveen et al., 2001b; Vineberg et al., 2002; Zelefsky et al., 2000; Wu et al.,
2000). Generally nine beams are considered to be sufficient (Bortfeld et al., 1990;
Mohan et al., 1995). In most recent planning studies concerning IMRT for the
treatment of oropharyngeal cancers, nine equiangular coplanar beams were used
(Manning et al., 2001; Vineberg et al., 2002; Wu et al., 2000). Wu et al. (2000) re-
ported that the quality of IMRT plans improved with increasing number of beams,
up to 9 beams. The differences between various beam geometries were, however,
not fully quantified. Both Vineberg et al. (2002) and Manning et al. (2001) did
not show data that supported their choice of nine beams.
In our institute segmental IMRT, also known as step-and-shoot IMRT, is used
(Nederveen et al., 2001b), in contrast with the use of dynamic MLC in the above
mentioned planning studies. For segmental IMRT, the optimal fluence maps ob-
tained by an inverse planning process, are divided in a discrete number of intensity
levels. By increasing the number of intensity levels, a better approximation of the
optimal fluence map is obtained. The use of segmental IMRT has the advantage
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of less complicated quality assurance procedures compared to dynamic MLC. For
practical implementation, the total number of MLC segments is an important pa-
rameter, since the treatment time is closely related to the number of segments.
The use of many segments will not only result in long treatment times but will
also result in many small segments with few monitor units. This might lead to
unacceptable uncertainties in the treatment delivery (Que, 1999). Potter et al.
(2002) reported that the treatment efficiency, represented by the total number of
MLC segments, firstly depended on the number of intensity levels used and sec-
ondly on the segmentation technique used. The number of intensity levels used to
obtain results close to the optimal intensity maps was 5 to 10 (Chui et al., 2001;
Keller-Reichenbecher et al., 1999; Potter et al., 2002).
The relation between the quality of a treatment plan and the number of beams in
combination with the number of segments is important for the clinical introduc-
tion of segmental IMRT. This relation has only been studied for two individual
head-and-neck cases (Keller-Reichenbecher et al., 1999). It was the purpose of this
work to investigate this relation in detail for the IMRT treatment of oropharyngeal
cancers and lymph nodes level II-IV in a clinical setting. Few beams with many
segments, i.e. a better approximation of the optimized fluence, might give similar
results than many beams with few segments. For this purpose, the planning soft-
ware (PLATO) and linear accelerator (Elekta) available at our department will be
used. The results will be used for developing an efficient and reliable segmental
IMRT technique.
Table 3.1: The original tumor site and TNM clasification.
Patient Tumor site TNM
1 ant.∗ faucial pillar T1 N0 M0
2 tonsil T1 N0 M0
3 tonsil T2 N0 M0
4 tonsil T2 N0 M0
5 tonsil T2 N0 M0
6 base of tongue T2 N0 M0
7 vallecula T3 N0 M0
8 tonsil T3 N0 M0
∗ anterior
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Figure 3.1: The contours of various volumes of interest delineated
in a transversal plane. For the primary tumor the gross tu-
mor volume (GTV) and the clinical target volume (CTV)
are delineated as well as the planning target volume (PTV)
of the GTV (PTVGTV ) and the CTV (PTVCTV ). Further-
more the CTV and the PTV of ipsilateral and the contralat-
eral lymph node containing regions (ILLN and CLLN) are
delineated. Finally the build-up region around the primary
target is shown.
3.2 Method
3.2.1 Patients
Eight patients previously treated with conventional radiotherapy for oropharyngeal
carcinoma at our institute (Table 3.1), were replanned for this study. All patients
underwent a planning computer tomography (CT) scan with 3-5 mm slice inter-
vals, which was transferred to our treatment planning system (PLATO RTS 2.4,
Nucletron Ltd., Veenendaal, NL). The clinical target volume (CTV) of the lymph
node containing regions, the CTV of the primary target and the organs at risk
(OAR; the parotid glands, the brain and the spinal cord) were delineated by a
physician (Fig. 3.1). According to the protocol used in our department, the mar-
gins necessary to account for microscopic invasion, applied to the GTV to obtain
the CTV of the primary tumor differ for each direction: 2 cm cranial; 1 cm caudal,
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ventral and medial; 0.5 cm lateral and dorsal. For the delineation of the CTV of
the lymph node containing regions the guidelines of Wijers et al. (1999) and Nowak
et al. (1999) were used. The cranial border of the lymph node containing region
is at the base of skull for both sides. A margin of 5 mm was applied to each CTV
to take into account the set-up uncertainties and organ motion, resulting in the
planning target volume (PTV) of the CTV of the primary tumor (PTVCTV ), the
PTV of the ipsilateral lymph nodes (PTVILLN ) and the PTV of the contralateral
lymph nodes (PTVCLLN ). No margins were applied to the organs at risk. The
intention was to deliver a extra dose to the primary tumor, therefore an extra
volume was delineated (PTVGTV ), which is the GTV with an extension of 5 mm.
Furthermore an extra volume was delineated around the PTVCTV with a margin
of 5 mm in order to guide the optimization process. The optimization program can
be forced to deliver the build-up of the dose to the prescribed dose to the primary
PTV inside this volume (Fig. 3.1). Thus when the primary PTV overlaps with
the PTV of the lymph node containing region, the dose gradient from the dose
prescribed to the lymph nodes to the dose prescribed to the primary target should
be within this volume. All the extensions were limited in the region containing the
skin, where the PTV was adjusted by hand when necessary to assure a minimal
distance of 5 mm between the PTV and the skin. The minimal margin between
the PTVs and the spinal cord and the brain was approximately 10 mm.
3.2.2 Dose prescription
Conventionally, the prescribed dose to the lymph nodes is 50 Gy (2 Gy/fraction; 5
times weekly) and the prescribed dose to the primary tumor 70 Gy (2 Gy/fraction;
5 times weekly) in our institute. In the presented study, the primary disease and
the electively treated regions are treated simultaneously with the same number of
fractions. Therefore a different fractionation is needed. The data of Mohan et al.
(2000) were used to determine the fractionation schedule, using a α/β ratio of
20 Gy and an accelerated tumor clonogen doubling time of 4 days. This resulted
in a prescribed dose of 54 Gy (1.8 Gy/fraction; 5 times weekly) for the elective
irradiation of the lymph nodes and a prescribed dose of 66 Gy (2.2 Gy/fraction;
5 times weekly) for the CTV of the primary tumor. An extra dose of 3 Gy was
planned for the GTV in order to increase the TCP, resulting in a total prescribed
dose to the GTV of 69 Gy (2.3 Gy/fraction; 5 times weekly). The dose to all target
volumes was delivered in 30 fractions, resulting in a simultaneous integrated boost
IMRT strategy (Mohan et al., 2000). The maximum dose allowed to the CNS and
the spinal cord was 45 Gy. Since the parotid glands are located adjacent to the
lymph node containing regions, part of the volume is overlapping with the PTV
of the lymph node containing regions, which should receive the prescribed dose.
The homogeneous irradiation of the target volumes was the most important aim.
Sparing of the parotid gland will be obtained by reducing the dose to the none
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Figure 3.2: The optimized fluence map for an IMRT beam (a) and
the fluence after sequencing for segmental IMRT, dividing
the intensity values in 15 (b) and 5 (c) equidistant levels.
overlapping parts without affecting the dose to the target volumes (van Asselen
et al., 2002).
3.2.3 Inverse planning
IMRT plans were generated using the inverse treatment-planning module ITP
of PLATO (version 1.0). This is a commercially available version of the KonRad
program, developed by the Bortfeld group (Bortfeld et al., 1993). The ITP module
optimizes the fluence for a fixed beam geometry to obtain a dose distribution that
best fits a series of dose constraints. For the target volumes a maximum and
minimum dose is specified. For organs at risk only a maximum dose is specified.
The relative weight of these constraints is tuned with so called ’penalties’. All
dose constraints are related to a given contour. Therefore the judicious choice
of contours is important for dose painting. When the contours are overlapping,
the overlapping volume is assigned to one of the volumes during the optimization
process. The parotid glands for example overlap with the PTV of the lymph nodes.
During the optimization the overlapping volume is considered to be PTV, since the
main goal is to deliver the prescribed dose to the lymph nodes and not reducing
the dose to the parotid gland.
A standard set of dose constraints (van Asselen et al., 2002) was determined by
systematically varying the penalties, minimum en maximum dose values. For this
purpose we used a generic patient including all PTVs and OARs. The starting
point was to irradiate only the PTVs without considering the organs at risk. When
acceptable dose homogeneity was achieved within the PTVs, organs at risk were
added to the optimization process. Since the dose constraints are relative to each
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other, the settings of the target volumes did not need to be adjusted and the
constraints of the organs at risk could slowly be increased in relative importance.
Increasing the penalty was stopped when the volume of the PTVs receiving 95%
of the prescribed dose reduced significantly. After obtaining the standard set, it
was tested on 3 other patients using three different beam geometries. In each case,
clinically acceptable results were obtained and further individual adjustments of
the constraints only resulted in mild changes in the dose parameters. In this way a
set of dose constraints was obtained which ensures dose homogeneity to the PTVs.
This standard set, using moderate sparing for the parotid glands (van Asselen
et al., 2002), was then used for all IMRT plans presented in this paper.
During the optimization, a fluence matrix for each beam angle is generated and
iteratively adjusted resulting in a dose distribution matching the prescription as
closely as possible. For the delivery of the optimized fluence we use step-and-shoot
IMRT applying the Elekta MLC (Elekta Oncology Systems, Crawely, UK). The
standard ITP sequencer for the Elekta MLC was used for the sequencing procedure.
The optimized intensity values of each fluence map were therefore subdivided into a
number of equidistant levels. This sequencer is based on the algorithm of Convery
and Webb (Convery and Webb, 1998) and tends to minimize the effect of the
transmission of the collimators, the leafs and the tongue-and-groove region. In
order to minimize the number of segments, a 1-D median filter is applied to the
theoretical fluence with a width of 3 bixels. An example of an optimized fluence
map and the resulting sequenced fluence map is shown in figure 3.2.
The fluence matrix had a resolution of 1 × 1 cm2 in the isocenter. The resolution
of the dose calculation matrix, for the iterative dose optimization, is 2.9 mm. After
sequencing, the dose distribution as actually delivered, is recalculated using a 3D
planning system (PLATO RTS version 2.5) using a resolution of 3–4 mm for the
dose calculation matrix.
For each patient, the dose distribution was optimized using a different number of
equiangular beams (3, 5, 7 and 9), with the gantry angle of the first beam at 0
degrees. The number of segments cannot be varied in a direct way.
Theoretical fluence with a continuous intensity distribution was converted into a
deliverable fluence with distinct intensity levels using 5, 7, 10 or 15 equidistant
intensity levels. It should be noted that the number of resulting segments in a
beam could be much larger than the number of intensity levels. The variations in
number of beams and intensity levels resulted in 16 dose distributions for a single
patient.
3.2.4 Analysis of the dose distribution
The dose received by 95 % of the PTV (D95) and the dose received by 5 % of
the PTV (D5) were calculated. The difference between the D95 and D5, D95−5,
was used as a parameter indicating the homogeneity of the dose distribution. The
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Figure 3.3: An example of the dose distribution in a transversal,
coronal and sagittal plane. The cross wire in each plane indi-
cates the intersection of the other two planes. The volumes
of interest are delineated. The doses values 51.3, 62.7 and
65.6 Gy are the 95 % doses of the lymph nodes, PTVCTV
and PTVGTV respectively.
volume receiving less than 95 % of the prescribed dose (V<95%) and more than
105 % of the prescribed dose (V>105%) were used as parameters indicating un-
derdosages and overdosages respectively. For the PTV of the lymph nodes the
volume receiving less than 90 % of the prescribed dose was also calculated. Fur-
thermore, the mean dose to the target volumes was calculated. For the PTVCTV
the dose distribution for the part which was not overlapping with the PTVGTV
was used in the analysis, since the overlapping part should receive the dose to the
PTVGTV . Consequently the PTVCTV is a shell around the PTVGTV . The PTVs
of the lymph nodes are overlapping with the PTVCTV . In the analysis of the dose
distribution only the part which is not overlapping is taken into account because
the overlapping part should receive the dose prescribed to the PTVCTV .
The mean dose to the parotid glands was calculated, including the overlapping
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volume, since the mean dose is the best known predictor for the salivary function
of the parotid glands after radiotherapy and can be used to calculated the NTCP
for xerostomia (Roesink et al., 2001; Eisbruch et al., 1999). The data of Roesink
et al. (2001) were used to calculate the NTCP for the parotid glands using the
model of Lyman (1985) with a TD50 of 39 Gy, a slope parameter m of 0.45 and
a volume parameter n of 1 (one year after radiotherapy). For statistical analysis
of the mean dose to the parotid glands a One-Way ANOVA procedure was used.
Differences were considered to be statistically significant when p < 0.05.
In order to evaluate the dose to the spinal cord and the CNS the maximum dose
was calculated (Dmax). The maximum dose was defined as the highest dose deliv-
ered to a total volume of at least 1 cm3.
The dose to the body, i.e. the volume not containing the target volumes or organs
at risk, was studied by determining the volume of the body receiving more than
60 Gy and 70 Gy (V>60Gy and V>70Gy).
3.3 Results
3.3.1 Primary tumor
Highly conformal dose distributions were obtained using IMRT for the treatment
of oropharyngeal cancers (Fig. 3.3). The mean dose to the PTVGTV was on average
69.4 ± 0.8 Gy (1 standard deviation, SD), which was close to the prescribed dose
for this volume. The mean dose to the PTVCTV was on average 66.7 ± 0.7 Gy (1
SD). The dose homogeneity, indicated by D95−5, of the dose distribution within
the PTVGTV and the PTVCTV varied for the different combinations of numbers of
beams and intensity levels (Fig. 3.4). In general, the dose homogeneity increased
when the total number of segments increased. The dose homogeneity was inde-
pendent of the beam geometry. In order words, the dose homogeneity was similar
when the IMRT plans for various beam geometries had a similar total number of
segments. Only for the PTVCTV irradiated with the 3 beams this was not the
case, similar number of segments resulted in worse dose homogeneity compared to
irradiation with 5 beams. When more than approximately 100 segments are used,
however, only limited further improvement in dose homogeneity was observed (Fig.
3.4).
The part of the PTVGTV which received a dose less than 95 % of the prescribed
dose was small ( < 1 % of the volume) when more than approximately 100 seg-
ments were used (Table 3.2). The underdosed part of the PTVCTV was larger
and increased when fewer beams were used (Table 3.2). The overdosed area of the
PTVGTV was relatively small for most cases. On average V>105% was 7.2 ± 13.6
(1 SD) % , 3.3 ± 4.1 (1 SD) % , 0.9 ± 1.7 (1 SD) % and 1.8 ± 5.0 (1 SD) % for 3,
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Figure 3.4: The dose homogeneity of the PTVGTV (a) and
PTVCTV (b) as a function of the total number of segments
for 3, 5, 7 and 9 beams. Each data point is the mean value
of 8 patients. The error bar indicates 1 standard deviation.
5, 7 and 9 beams respectively. The overdosed volume of the PTVCTV was larger
than that of the PTVGTV due to the dose gradient, from 66 to 69 Gy, which is
located in this shell around the PTVGTV . On average the V>105% of the PTVCTV
was 14.4 ± 9.6 (1 SD) % , 13.1 ± 7.1 (1 SD) % , 10.4 ± 4.3 (1 SD) % and 12.9
± 5.0 (1 SD) % for 3, 5, 7 and 9 beams respectively. The V>105% increased when
fewer segments were used.
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Table 3.2: The volume (%) receiving a dose lower than 95 % of
the prescribed dose of the planning target volume of the
gross tumor (PTVGTV ), clinical target volume (PTVCTV ),
the contra- and ipsilateral lymph node containing region
(PTVCLLN and PTVILLN ) for different combinations of
number of beams and intensity levels used for sequencing.
Beside the mean (m) V<95% over 8 patients, the standard
deviation (SD) is shown.
beams levels segm. PTVGTV PTVCTV PTVCLN PTVILN
m (SD) m (SD) m (SD) m (SD)
3 5 26 11.4 (16.6) 15.3 (6.6) 14.2 (5.3) 6.0 (4.7)
3 7 36 4.1 (3.6) 12.5 (5.6) 11.8 (5.0) 6.2 (4.2)
3 10 49 2.4 (2.1) 11.6 (5.7) 11.0 (4.7) 5.4 (4.4)
3 15 69 2.8 (2.1) 12.1 (5.3) 11.3 (4.7) 4.8 (3.8)
5 5 52 2.1 (2.2) 6.3 (3.4) 7.6 (4.6) 9.3 (6.3)
5 7 67 2.1 (1.7) 6.5 (3.0) 6.9 (3.6) 6.1 (3.5)
5 10 88 0.4 (0.3) 5.2 (2.4) 6.0 (3.0) 3.9 (1.8)
5 15 121 0.2 (0.2) 4.6 (2.2) 7.1 (5.7) 4.3 (2.2)
7 5 74 1.8 (2.5) 5.3 (3.8) 6.2 (2.9) 4.3 (2.5)
7 7 99 0.6 (1.2) 4.8 (3.1) 4.9 (2.6) 3.6 (2.1)
7 10 131 0.3 (0.5) 4.2 (2.2) 4.3 (2.6) 3.4 (2.0)
7 15 176 0.1 (0.1) 4.0 (2.3) 4.4 (2.7) 3.3 (2.3)
9 5 94 0.7 (1.2) 4.4 (2.5) 4.2 (2.6) 3.9 (2.0)
9 7 127 0.1 (0.2) 3.4 (1.8) 3.7 (2.6) 3.4 (2.5)
9 10 164 0.1 (0.2) 3.6 (1.8) 3.2 (2.4) 3.0 (2.2)
9 15 222 0.1 (0.1) 3.4 (1.8) 2.9 (2.1) 2.9 (1.7)
3.3.2 Lymph nodes
The mean dose to the PTV of the ipsilateral lymph nodes (PTVILLN ) and the PTV
of the contralateral lymph nodes (PTVCLLN ) was on average 55.5 ± 0.7 Gy and
55.0 ± 0.5 Gy (1 SD) respectively. The dose homogeneity of the PTVILLN (Fig.
3.5) improved, as was observed for the primary targets, when the total number of
segments increased and did not depend on the number of beams. This was not the
case for the dose homogeneity of the PTVILLN for the 3-beam plans. The dose
homogeneity of the PTVCLLN however, showed a different trend. For each beam
geometry the saturation level was reached at a different value of dose homogeneity.
In other words, the dose homogeneity increased with increasing number of beams
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Figure 3.5: The dose homogeneity of the PTVCLLN (a) and
PTVILLN (b) as a function of the total number of segments
for 3, 5, 7 and 9 beams. Each data point is the mean value
of 8 patients. The error bar indicates 1 standard deviation.
for a similar total number of segments.
The V<95% increases when a smaller number of intensity levels was chosen and
for a smaller number of beams (Table 3.2), especially for the contralateral part of
the lymph nodes. The volume receiving less dose than 90 % of the prescribed dose
(V<90%) for the PTVILLN was smaller than 1 % for the plans with more than
approximately 90 segments. For a smaller number of segments V<90% amounted
to 1-2 %. For the PTVCLLN , V<90% was on average 4.2, 1.6, 1.3 and 0.8 % for 3,
5, 7 and 9 beams respectively. The overdosage of the lymph nodes was relatively
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Figure 3.6: The volume receiving more than 105 % of the pre-
scribed dose (V>105%) to the contralateral (a) and ipsilat-
eral (b) lymph node containing region. Each data point is
the mean value of 8 patients. The error bar indicates 1 stan-
dard deviation.
large (Fig. 3.6), especially for the ipsilateral part which was close to the high dose
areas. It was also observed that the overdosed volume depended on the number of
beams and number of segments, especially for the contralateral side.
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3.3.3 Spinal cord and brain
On average Dmax of the brain was 33.6 Gy (range 11.4 – 46.8 Gy). For one case,
with 3 beams and 7 intensity levels, the maximum dose did exceed 45 Gy. The
average of the maximum dose to the spinal cord was 32.6 Gy and did not vary
much from patient to patient (range 30.2 – 37.5 Gy).
3.3.4 Body
No large difference was observed between the high dose volumes for 5, 7 and 9
beams. On average V>60Gy and V>70Gy were 34.2 cm3(range 13.1 – 59.0 cm3) and
0.4 cm3 (range 0.0 – 2.3 cm3) respectively. These volumes decreased when more
segments were used. The high dose volume of the body for 3 beams was larger
than for the other beam geometries. On average V>60Gy and V>70Gy were 45.2
cm3 (range 11.6 – 81.8 cm3) and 3.0 cm3 (range 0.0 – 9.7 cm3) respectively. High
dose volumes in the body appeared not only near the target volume but also in
the posterior part of the neck for the 3-beam geometry.
3.3.5 Parotid glands
The mean dose to the parotid glands did not depend on the number of intensity
levels. The variation in mean doses for a varying number of intensity levels using
the same beam geometry was smaller than 0.5 Gy. The mean dose was, however,
influenced by the beam geometry, especially for the contralateral parotid gland
(Fig. 3.7). On average the mean dose to the contralateral parotid gland was 32.6
Gy for the 5 beam plans. This was lower than the average mean dose for the
3, 7 and 9 beam plans, which amounted to 38.0, 35.7 and 34.4 Gy, respectively.
Although small, the difference in the mean doses for the different beam geometries
were statistically significant (p < 0.001). There was no statistically significant
difference between the mean doses of the ipsilateral parotid gland (on average
42.6 Gy) calculated for the 5,7 and 9 beam plans. The mean dose for the 3 beam
geometry was on average 45.3 Gy, and was significantly higher (p < 0.001) than
the mean doses of the other beam geometries.
NTCP values were calculated using the mean doses to the parotid glands. This
resulted in mean NTCP values for the contralateral parotid gland of 0.48, 0.36, 0.43
and 0.40 for the 3, 5, 7 and 9 beam plans, respectively. For the ipsilateral parotid
gland the NTCP values were higher, 0.64 for the 3 beam plan and approximately
0.58 for the other beam geometries.
3.3.6 Segments
The total number of segments after sequencing ranged from 22 to 234 depending
on the number of beams and intensity levels. The differences between the seg-
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Figure 3.7: The mean dose for the contralateral and ipsilateral
parotid gland for 3, 5, 7 and 9 beams. The mean dose is
averaged over 8 patients and 4 numbers of intensity levels.
The error bar indicates 1 standard deviation.
mented fluence map and the optimized fluence map were small when 15 intensity
levels were used, while for 5 intensity levels distinct differences were observed (Fig.
3.2). There was a linear relation between the number of intensity levels and the
resulting number of segments after the sequencing process (Fig. 3.8). The number
of segments for a single beam was approximately 1.4 times the number of intensity
levels. The delivery time of an IMRT plan with 7 beams and approximately 80 seg-
ments was 13-14 minutes. For approximately 150 segments the IMRT plans were
executed in 24-26 minutes. The delivery times were reduced by approximately 2
minutes when 5 beams were used with a similar number of segments.
3.4 Discussion
In this planning study on the segmental IMRT treatment of oropharyngeal tu-
mors and lymph nodes level II-IV, various combinations of beam geometries and
intensity levels were investigated. The dose homogeneity within the target volumes
mainly depended on the total number of segments and was only slightly influenced
by the number of beams. For the PTVGTV , PTVCTV and PTVILLN the dose ho-
mogeneity, using 5, 7 and 9 beams, was similar when the total number of segments
was similar. For the contralateral lymph nodes, however, the dose homogeneity
improved for plans with a constant number of segments when more beams were
used. The difference in dose homogeneity between the plans with 7 or 9 beams
with many segments was small for all target volumes, indicating that more than 7
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Figure 3.8: The total number of intensity levels in which the the-
oretical fluence is divided and the resulting total number of
segments after sequencing.
beams are not needed. In a study of Wu et al. (2000), IMRT using various beam
geometries was analyzed. Although not quantified in detail, they reported that
the quality of the IMRT plan improved when the number of beams increased,
up to 9 beams. Vineberg et al. (2002) used 9 beams for the IMRT treatment of
oropharyngeal cancer, in order to have sufficient degrees of freedom to achieve
high-quality dose distributions. Although beam optimization becomes less impor-
tant when 7 or more beams are used (Stein et al., 1997; So¨derstro¨m and Brahme,
1995; Rowbottom et al., 2001), Pugachev et al. (2001) showed improvements in
the dose distribution for a nasopharyngeal case using 9 noncoplanar beams when
beam angle optimization was applied.
The underdosage of the PTVGTV was small (Table 3.2). V<95% ammounted to 0.1
– 0.3 %, for the 7- and 9-beam plans with many segments. For the PTVCTV the
V<95% was larger and amounted to 3 – 4 % for the IMRT plans with the best dose
homogeneity. The volumes within the target volume receiving a dose lower than
95 % of the prescribed dose were always located near the border of the volume. In
most cases they were observed at the posterior side of the PTV, relatively close
to the spinal cord and the brain. The V<95% of the PTV of the lymph nodes were
comparable with the V<95% of the PTVCTV . Since most of the PTV of the lymph
nodes received a dose larger than 90 % of the prescribed dose (on average 99 % of
the PTV) this will still result in low risk of metastasis (Withers et al., 1995a).
Although the dose homogeneity to the target volumes was considered the most
important, it was possible to achieve mean doses to the contalateral parotid gland
of approximately 35 Gy, the dose to the ipsilateral gland was approximately 10
Gy higher. Using conventional conformal techniques mean doses of approximately
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50 – 70 Gy are obtained. For the IMRT plans this results in a NTCP value of
approximately 0.40 for the contralateral parotid gland. Several groups studied the
IMRT treatment of oropharyngeal cancers and elective irradiation of the lymph
nodes. Vineberg et al. (2002) reported mean doses ranges of approximately 17 – 34
Gy and 28 – 53 Gy for the contralateral and ipsilateral parotid glands respectively,
using a contralateral parotid-sparing protocol (Eisbruch et al., 1998). The homo-
geneity of the dose in the target volumes was within 5 % of the prescribed dose.
Using a simple three-dimensional conformal radiotherapy technique with beam in-
tensity modulation van Dieren et al. (2000) reported a mean dose to the parotid
glands of 41.5 Gy, while the PTV was fully covered by the 95 % isodose surface
for most plans. Chao et al. (2000) reported a mean dose of 22.4 ± 5.22 Gy (1 SD)
for irradiations involving the primary tumor and neck nodes. The mean volume
of the targets receiving less than 95 % of the prescribed dose was 3 % ± 1.4 %
(1 SD). A tomotherapy-based IMRT system was used. Using a planning organ-at-
risk volume and a dynamic multileaf collimation technique, Manning et al. (2001)
reported that 0.1 ± 0.0 % (1 SD) of the contralateral parotid received a dose more
than 30 Gy for three cases. The coverage of the elective treated volume (ETV)
was however, diminished, i.e. 92.5 ± 4.4 % (1 SD) of the ETV received a dose
higher than or equal to the prescribed dose (54 Gy). Variation in the mean dose
to the parotid gland and target dose homogeneity reported by the various groups
may be the result of different treatment planning strategies and different IMRT
delivery techniques. Also the volumes will not always be delineated in the same
way. For example, the cranial border of the lymph node containing region is at
the base of skull for both sides in our study, while others might lower the cranial
border in order to spare the contralateral parotid gland. The influence of lowering
this cranial border and the associated risks are currently investigated.
The mean dose to the parotid glands did not decrease using additional beams. In
this paper, the mean dose to the contralateral parotid gland was statistical sig-
nificantly lower for 5 beams than for the other beam geometries. This might be
due to the fact that in the five-beam geometry, a favorable beam angle is present.
Another reason might be the use of a fixed set of dose constraints and penalties
independent of the beam geometry. The reason for this effect will be further in-
vestigated. There was also no effect of the number of intensity levels on the mean
dose to the parotid gland. Using more intensity levels might result in a sharper
dose gradient between the parotid glands and the lymph nodes. The mean dose,
which is the best known prognostic factor for xerostomia (Roesink et al., 2001;
Eisbruch et al., 1999), is, however, not very sensitive to a sharper dose gradient
and is dominated by the overlapping volume receiving the prescribed dose (54
Gy). Keller-Reichenbecher et al. (1999) reported for two head-and-neck cases that
using additional beams and intensity levels, it was possible to improve the dose
homogeneity in the target volume. This, however, did not automatically result in
a better sparing of OARs. For a nasopharyngeal case, Chui et al. (2001), reported
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that increasing the number of levels resulted in improved target coverage, but the
critical organ protection was little affected.
The total number of segments after sequencing ranged from 22 to 234 depending
on the number of beams and intensity levels. The absolute number of resulting
segments depends on the sequencing technique (Chui et al., 2001; Potter et al.,
2002; Que, 1999). The number of segments needed per field per intensity level
was 1.4, which is similar to the value of 1.3 (±0.2) determined by Potter et al.
(2002) for three head and neck cases. The number of segments is also influenced
by the resolution of the fluence matrix. Although a finer resolution might result
in an improved dose distribution, it could also result in more segments and thus
in longer treatment times. We therefore choose for a resolution of 1 cm × 1 cm in
this work and will further investigate the influence of a higher resolution.
When the total number of segments increased from approximately 100 to ap-
proximately 150, relatively little improvement in dose homogeneity was observed.
When many segments are used, the individual segments will become smaller. The
use of many small segments has dosimetric disadvantages such as a larger contri-
bution from leaf transmission and uncertainties caused by small field dosimetry.
Furthermore, many segments result in longer treatment times and consequently
an increased risk for intrafraction motion of the patient (van Asselen et al., 2003).
The optimization in radiotherapy is a multi-parameter problem. Parameters such
as treatment modality, beam energy, number and orientation of beams and the
fluence profiles all require optimization to obtain the best possible treatment plan
for an individual patient (Rowbottom et al., 1999). The optimization of all pa-
rameters requires too much time even on a research basis. We therefore choose a
reasonable sub-set of these parameters and investigated for this sub-set the best
clinically achievable treatment plan. The patients were all planned using the same
parameters, what makes the introduction of IMRT more easy since this would be
less time consuming than individually optimize the parameters for each patient.
Individual optimization might, however, result in a slightly better treatment plan.
Although the optimal plan for each individual patient might not be achieved using
the class solution, the presented IMRT plans resulted, however, in highly confor-
mal and clinically acceptable plans. The findings of this paper are now used for
the clinical introduction of IMRT for the treatment of oropharyngeal tumors at
our department and can be used as a starting point for further improvements.
3.5 Conclusion
A subset of treatment parameters has been investigated for the segmental IMRT
treatment of oropharyngeal cancers and the elective treatment of the lymph nodes
level II-IV. Significant parotid sparing was obtained for 5, 7 and 9 beams, with
acceptable dose homogeneity within the target volumes and dose escalation in the
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GTV. The dose homogeneity in the PTVs depended mainly on the total number of
segments and was only slightly influenced by the number of beams. The number
of segments did not influence the mean dose to the parotid glands. When only
the dose distribution to the target volumes is considered, 7 beams and a total
of approximately 100 segments were sufficient to achieve a highly conformal and
homogeneous dose distribution. Between 100 and 150 segments little improvement
in the dose distribution was observed.
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Abstract
Purpose: The aim of this paper is to quantify the importance of the reduction of posi-
tioning margins applied to the clinical target volume (CTV) on the dose distribution of
the parotid gland for different intensity modulated radiotherapy (IMRT) strategies for
the treatment of oropharyngeal cancer.
Methods and Materials: CTVs and organs at risk were delineated in the planning com-
puted tomographic (CT) scans of three patients. Margins of 0, 3, 6 and 9 mm were applied
to the CTVs in order to obtain the planning target volumes (PTVs). Three IMRT strate-
gies were used to optimize the dose distribution.
Results: The analysis of the three IMRT strategies resulted in: (1) an optimal dose distri-
bution in the PTV, (2) optimal dose distribution in the PTV while sparing the parotid
gland and (3) more parotid gland sparing but at expense of the dose homogeneity in the
PTV. The mean parotid dose increased linearly with increasing margin by approximately
1.3 Gy per mm. As a result the normal complication probability (NTCP) for xerostomia
decreased when smaller margins were applied. Reducing the margin from 6 to 3 mm
resulted in an NTCP reduction of approximately 20 %.
Conclusion: Reducing the CTV-PTV margin by improving the patient position accuracy
may lead to a significant reduction of NTCP for the IMRT treatment of the oropharyngeal
tumors and lymph nodes level II.
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4.1 Introduction
A common and severe complication of the irradiation of cancers in the head and
neck region is xerostomia. The level of xerostomia for an individual case depends
on the location of the main salivary glands relative to the target volumes. In case
of oropharyngeal tumors, at least one parotid gland is located near the primary
tumor and both are located adjacent to the lymph node containing region level
II, which are treated electively. Irradiation of the main salivary glands is therefore
inevitable, which can cause reduction of the salivary flow and change in salivary
composition leading to a number of clinical sequela including xerostomia, difficul-
ties in mastication and speech, changes of taste, increased risk of caries and oral
infections, chronic esophagitis and altered nutrition (Hamlet et al., 1997; Mandel,
1987; Vissink et al., 1988; Wright, 1987). These severe side effects have a negative
impact on the quality of life of the patient (De Graeff et al., 1999; Huguenin et al.,
1999).
Conventionally two opposed lateral fields are used for the irradiation of the orophar-
ynx. Therefore dose values up to the prescribed dose (50-70 Gy) cannot be avoided
to the parotid glands. In a prospective study Roesink et al. (2001) showed that a
normal tissue complication probability (NTCP) of 50 % for xerostomia is obtained
when the mean dose to the parotid glands is 39 Gy. Eisbruch et al. (1999) reported
a mean dose of 28.4 Gy for a NTCP of 50 % . Lower NTCP values (< 50 %) and
thus lower mean doses are, however, desirable.
Various studies showed reduction of the dose to the parotid glands using intensity
modulated radiotherapy (IMRT) (De Neve et al., 1999; Butler et al., 1999; Wu
et al., 2000; Manning et al., 2001; Eisbruch et al., 1998). With IMRT it might
therefore be possible to preserve the function of the parotid glands, while the tar-
get volumes still receive an acceptable dose. The reduction of the dose is depends
on the exact implementation of the IMRT technique, which determines the steep-
ness of the dose gradient between the parotid glands and the PTVs. Secondly, the
margins applied to the clinical target volume (CTV) in order to obtain the plan-
ning target volume (PTV) are important. These margins can cause overlapping
areas between the PTVs and the parotid glands, unavoidably leading to high dose
regions in these glands. The size of these margins depends on set-up uncertainties
(Hurkmans et al., 2001b; De Boer et al., 2001) and organ motion. Improving the
positioning of patients and position verification results in smaller margins, and
might consequently result in a lower NTCP for xerostomia.
It is the purpose of this work to quantify the influence of the CTV-PTV margin,
i.e. the importance of more accurate position verification, on the dose distribution
of the parotid glands and secondly to investigate the influence of different IMRT
strategies to the dose to the parotid glands and the PTVs for the irradiation of
oropharyngeal tumors and lymph nodes level II.
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4.2 Materials and method
4.2.1 Patients
The data of three patients with oropharyngeal tumors were used. Patient A had
a tumor localized in the anterior faucial pillar (T1N0M0), patient B had a tumor
localized in the tonsil (T2N0M0) and the tumor of patient C was localized in
the vallecula (T3N0M0). A planning computer tomography (CT) with 3 mm slice
intervals was available for these patients. The CT-images were transfered to our
treatment planning system (PLATO RTS 2.4, Nucletron Ltd., Veenendaal, NL),
where the CTV of the lymph node containing regions, the CTV of the primary
target and the organs at risk (OAR; the parotid glands, the brain and the spinal
cord) were delineated by a physician. According to the protocol used in our depart-
ment, the margins applied to the GTV to obtain the CTV of the primary tumor
differ for each direction: 2 cm cranial; 1 cm caudal, ventral and medial; 0.5 cm
lateral and dorsal. For the delineation of the CTV of the lymph node containing
regions the guidelines of Wijers et al. (1999) and Nowak et al. (1999) were used.
The volumes of the CTVs of the primary tumor were 97.2, 70.2 and 68.6 cm3 for
patient A, B and C, respectively. The mean volume of the parotid glands was 26.3
cm3 (range 22.4–31 cm3).
Margin of 0, 3, 6 and 9 mm were applied to the CTV in three dimensions using an
automatic volume extension (PLATO VSS). This resulted in four different PTVs
for each of the three CTVs of an individual patient (Fig. 4.1). The margin was a
multiple of 3 mm since the CT was taken with 3 mm intervals. The extension of the
CTV was limited in the region containing the skin, where the PTV was adjusted by
hand when necessary to assure a minimal distance of 5 mm between the PTV and
then skin. The minimal margin between a PTV and the spinal cord was approxi-
mately 10 mm. An extra volume was delineated around the PTV of the primary
target with a margin of 5 mm to the PTV in order to steer the dose distribution.
The optimization program can be forced to deliver the build-up of the dose to the
prescribed dose to the primary PTV inside this extra volume. Thus when the pri-
mary PTV overlaps with the PTV of the lymph node containing region, the dose
gradient from the dose prescribed to the lymph node containing region (54 Gy)
to the dose prescribed to the primary target (66 Gy) will be located in this volume.
4.2.2 Intensity modulated radiotherapy planning
IMRT plans are generated using the inverse treatment planning module ITP of
PLATO. This module is a commercially available version of the KonRad program,
developed by the Bortfeld group (Bortfeld and Schlegel, 1993). The ITP module
optimizes the fluence for a fixed beam geometry to obtain a dose distribution
that best fits a series of dose constraints. For the target volumes a maximum and
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Figure 4.1: The contours of patient B delineated in a transversal
plane. The PTVs of the primary tumor (PTVP−x) and the
right and left lymph node containing region (PTVLL−x and
PTVLR−xrespectively) are shown for different margins ap-
plied to the CTVs. The number in the subscript indicates
the applied margin in millimeters.
minimum dose is specified, for OARs only a maximum dose. The relative weight
of these constraints is tuned with so-called ’penalties’. All dose constraints are
related to a given contour. Therefore the judicious choice of contours is important
for dose painting.
During the optimization, a fluence matrix for each beam angle is generated and
iteratively adjusted resulting in a dose distribution matching the prescription as
closely as possible. For delivering such a fluence in practice, we plan to use step-
and-shoot IMRT, i.e. the modulated fluence is realized by delivering a discrete
number of irregularly shaped fields. The theoretical fluence with a continuous
intensity distribution is converted into a deliverable fluence with distinct intensity
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levels using sequencer software developed at our institute and incorporated into
the ITP software. The fluence matrix had a resolution of 1 × 1 cm2 in the isocenter.
The resolution of the dose calculation matrix, for the iterative dose optimization,
is 2.9 mm. After optimization, the dose distribution is recalculated with a three-
dimensional (3D) planning system (PLATO RTS version 2.4) using a resolution of
1.6 mm for the dose calculation matrix.
The prescribed dose to the PTV of the primary tumor was 66 Gy (2.2 Gy/fraction;
five times weekly), which is radiobiologically similar to 70 Gy (2 Gy/fraction; five
times weekly). For the elective irradiation of the lymph node containing regions 54
Gy (1.8 Gy/fraction; five times weekly) was prescribed, equivalent to 50 Gy in 25
fractions. The dose to the target volumes was delivered in a total of 30 fractions,
resulting in a simultaneous integrated boost strategy, i.e. different dose levels are
simultaneously delivered to different tissues in a single treatment session (Mohan
et al., 2000). The maximum dose to the brain and the spinal cord was 45 Gy.
In order to achieve a standard set of beam parameters and dose constraints which
can be used for the IMRT calculations, the number of beams and the value of the
penalties were systematically varied. This resulted in a beam geometry consisting
of seven coplanar beams equidistant, with the gantry angle of the first beam at
0◦. Beside the beam geometry, a standard set of dose constrains (Table 4.1) was
determined, which resulted in homogeneous dose distributions within the target
volumes and acceptable doses to the organs at risk. Fifteen intensity levels were
chosen for each beam. This is the maximum which can be chosen for step-and-
shoot IMRT.
For each margin, three different optimization strategies concerning the sparing
of the parotid glands were analyzed. In other words, three different sets of dose
constraints for the parotid glands are used in this paper:
set 1 The dose to the parotid gland is not taken into account during the optimiza-
tion process of the target volumes.
set 2 A penalty is assigned to the parotid gland which limits the dose during the
optimization process. The parotid is thus actively spared.
set 3 A more extreme version of the second set (a higher penalty), where the
optimization process is forced to reduce the dose to the parotid glands
further.
The penalty settings for the parotid glands were 0, 1 and 10 for dose constraint set
1, 2 and 3 respectively. The three different sets were used to determine the amount
of parotid sparing that can be achieved and to investigate the relation between
the sparing of the glands and the dose distributions in the PTVs.
It should be realized that the beam geometry and the set of dose constraints for
the volumes involved where the same for all 36 (3 patients × 4 margins × 3 dose
constrain sets for the parotid glands) IMRT plans, the constraints of the parotid
glands excluded.
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Table 4.1: The settings used for the optimization in PLATO ITP.
The penalty setting for the parotid glands (x) is varied.
VOI max dose penalty min dose penalty
PTVprimary tumor 66 100 66 100
PTVbuild−up 66 100 66 1
PTVlymph node 54 100 54 100
Body 40 10 - -
Spinal cord 30 100 - -
Brain 30 100 - -
Parotid gland 20 x - -
4.2.3 Analysis
In our institute the salivary function of 108 patients treated with radiotherapy for
various malignancies in the head and neck region was studied in detail (Roesink
et al., 2001). The data were fitted using the NTCP model proposed by Lyman
(1985). The data analysis showed that the mean dose to the parotid glands is a
predictor for the salivary function of the glands after radiotherapy and can be
used to calculate the NTCP. Therefore we calculated the mean dose to the parotid
glands in order to predict the NTCP value for the IMRT plans. Beside the data of
Roesink et al. (2001), the data of Eisbruch et al. (1999) were used to compare the
results for two different clinically obtained NTCP curves. Both used a maximum
likehood estimation of the NTCP model but found different parameter values. For
the same endpoint, i.e. less than 25 % of the baseline flow value at 1 year post-
radiotherapy, Roesink et al. (2001) found TD50 = 39 Gy and a slope m = 0.45
versus a TD50 = 28.4 Gy and slope m = 0.18 reported by Eisbruch et al. (1999).
A smaller value for m results in a steeper NTCP curve.
A two-tailed paired t-test, using the Bonferroni correction for multiple testing,
was used for statistical analysis of the mean dose. In the remainder of this paper,
differences were considered to be statistically significant when P < 0.05.
Beside the analysis of the dose volume histograms (DVHs), the dose to the PTVs
was evaluated by calculating the dose received by 95 % of the PTV (D95), the
dose received by 5 % of the PTV (D5) and the mean dose. For the spinal cord and
the brain, the dose received by 1 cm3 (Dmax) was evaluated, which is used as an
indicator of the maximum dose. The PTV of the primary target partially overlaps
the lymph node containing region (Fig 4.1). In the analysis of dose distribution of
the lymph node containing region, only the part of the lymph nodes which is not
overlapping the PTV of the primary tumor is taken into account.
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Figure 4.2: Dose distribution in a transversal plane obtained us-
ing 7 equidistant beams. A margin of 6 mm and dose con-
strain set 2 were used. The isodose of 30, 40, 51.3 (= 95 %
of 54 Gy) and 62.7 (= 95 % of 66 Gy) Gy are shown. Fur-
thermore the contours of the volumes of interest are shown.
4.3 Results
4.3.1 Target volumes
In general, highly conformal dose distributions were obtained using seven beams
and 15 intensity levels (Fig. 4.2). The mean dose to the various PTVs was close to
the prescribed dose. The average mean dose (averaged over all 36 plans) to the PTV
of the primary tumor was 66.2 Gy (range 65.4–67 Gy). For the PTV of ipsilateral
and contralateral lymph node containing region this the average mean dose was
54.8 Gy (range 54.4–55.3 Gy) and 54.5 Gy (range 53.7–55.2 Gy ) respectively.
The homogeneity of the dose distribution was different for the three sets of dose
constraints. The dose distribution calculated using set 1 or 2 were comparable
when the same margin was applied (Fig. 4.3), indicating that parotid sparing was
obtained without compromising the dose homogeneity in the PTVs. However, using
the dose constrain set 3, part of the lymph node containing regions did receive a
lower dose compared to the calculations for set 1 and 2 (Fig. 4.3). This was the case
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Figure 4.3: The DVHs of the PTV of the primary tumor (3 right
curves), the ipsilateral lymph node containing region (3
curves in the middle) and the ipsilateral parotid gland (3
left curves) for the 3 patients (a, b and c) calculated for 3
sets of dose constraints: no active sparing (solid line), mod-
erate sparing (dashed line) and heavy sparing (dotted line).
A margin of 6 mm was applied to the CTV.
for all patients and all margins used. The dose distributions of the PTVs calculated
for larger margins were slightly more inhomogeneous. The difference between D95
and D5, which characterizes the slope of the DVH, did not exceed 1 Gy for the
PTV of the primary tumor and the contralateral lymph containing region when
enlarging the margin for the same dose constrain set. In other words, 90 % of the
volume received a dose within a dose interval of 1 Gy. For the ipsilateral lymph
node containing region, values up to 2 Gy were calculated for a margin of 9 mm.
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Figure 4.4: The mean dose to the ipsilateral parotid gland of
patient B as a function of the margin applied to the CTV
for 3 dose constrain sets.
4.3.2 Spinal cord and brain
The maximum dose to the spinal cord and the brain were well below 45 Gy (table
4.2). The dose to the brain was not exceeding 42.9 Gy and the dose to the spinal
cord was not exceeding 32.5 Gy for all plans. The average Dmax of the spinal cord
was similar for the three patients with relatively small ranges. The variation in
the Dmax of the brain was however larger and differed from patient to patient. In
contrast with the Dmax of the spinal cord, the Dmax of the brain increased slightly
when the margin was enlarged.
4.3.3 Parotid gland
The mean dose to the parotid gland was largely influenced by the IMRT strat-
egy (Table 4.3). Using set 2, the mean parotid dose was reduced compared to the
calculation using set 1 by approximately 6 Gy. For dose constrain set 3 the mean
Table 4.2: The average Dmax and its range of all IMRT plans for
the spinal cord and the brain.
Brain Spinal cord
average Dmax (range) [Gy] average Dmax (range) [Gy]
patient A 30.5 (25.6–34.7) 31.5 (30.4–32.3)
patient B 37.5 (32.6–42.9) 29.9 (28.9–30.7)
patient C 23.8 (18.6–29.6) 30.1 (29.1–31.5)
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Table 4.3: The average mean dose (SD ≤ 8 %) to the parotid
glands (D¯) and the NTCP (using the data of Roesink et al.
(2001)) of the parotid glands for three sets of dose con-
straints and four different margins between the CTV and
PTV.
margin [mm]
0 3 6 9
D¯ [Gy] NTCP D¯ [Gy] NTCP D¯ [Gy] NTCP D¯ [Gy] NTCP
set 1 34.9 0.41 38.4 0.49 42.1 0.57 45.1 0.64
set 2 28.6 0.28 32.3 0.35 36.2 0.44 39.4 0.51
set 3 21.5 0.16 24.3 0.20 28.7 0.28 32.7 0.36
dose of the parotid glands could be reduced further by approximately 7 Gy. The
mean parotid dose increased approximately linearly with increasing margin, for all
parotid glands and the various set of dose constrains used (Fig. 4.4). The relation
between the margin and the mean dose was fitted by linear regression, for each
gland and for every dose constrain set separately. This resulted in an average slope
of 1.3 ± 0.2 (1 SD = standard deviation) Gymm for 18 fits. Consequently, when the
margin is increased by 1 mm, the mean dose to the parotid gland will increase
by approximately 1.3 Gy. The differences in mean dose between the IMRT plans
calculated using the three different sets and between the four different margins
were all statistically significant (P < 0.001).
NTCP values (Table 4.3) were calculated using the averaged mean dose of the
parotid glands and the NTCP data of Roesink et al. (2001). The range of NTCP
values was 0.16 – 0.63, depending on the margin and the IMRT strategy. The
relation between the margin and the NTCP was also approximately linear (Fig.
4.5 A). When a margin of 6 mm was used together with dose constraint set 2, i.e.
sparing of the parotid glands without compromising the dose homogeneity in the
PTVs, the average NTCP was 0.44. Using a margin of 3 mm the NTCP reduced
by approximately 20 % to a value of 0.35. The NTCP values were also calculated
using the data of Eisbruch et al. (1999) (Fig. 4.5 B). Only for set 3 (NTCP range
0.09–0.80) and set 2 (NTCP range 0.54–0.98), with small margins, low NTCP
values could be achieved using the data of Eisbruch et al. (1999). The range cal-
culated for set 1 was 0.90–1.00.
For each margin, the PTVs are overlapping the parotid glands. The result is that
a smaller part of the parotid gland (table 4.4) could be spared during the opti-
mization process when the margin was increased. The volume of the parotid gland
overlapped by the PTVs, relative to its original volume (relative overlapping vol-
ume) correlated linearly with the mean dose (Fig. 4.6). The data were fitted by
linear regression. When the relative overlapping volume of the parotid glands in-
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Table 4.4: The volume [cm3] of the parotid glands (I = ipsilateral,
C = contralateral) that is not overlapping the PTVs for 0,
3, 6, 9 mm margin between the CTV and the PTV.
patient A patient B patient C
I C I C I C
margin 0 27.4 31 26.1 22.4 25.6 25.4
margin 3 25.5 29.8 24.8 21.1 22.8 22.6
margin 6 23.1 27.5 22.5 18.3 19.4 19.2
margin 9 20.4 24.9 19.9 15.5 16.1 16.0
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Figure 4.5: The correlation between the NTCP and the margin
applied to the CTV calculated for 3 dose constrain sets using
the data of Roesink et al. (2001) (a) and Eisbruch et al.
(1999) (b). Data of Fig. 4.4 are used.
creased by 10 %, the mean dose to the parotid glands increased by approximately
3.5 Gy.
4.4 Discussion
In this work, the influence of the margins applied to the CTV on the dose to the
parotid gland for the treatment of oropharyngeal cancer was quantified. As ex-
pected the mean dose to the parotid glands increased when the margin between
the CTV and the PTV was enlarged. The parotid gland will, however, receive a
substantial dose even for very small margins, since it is located adjacent to the
lymph node containing region level II. The correlation between the mean dose
and the margin was approximately linear, with a slope of 1.3 Gymm , i.e. enlarging
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Figure 4.6: The correlation between the mean parotid gland dose
and the relative overlapping volume of the parotid gland, i.e.
the volume that is overlapping the PTV, for 3 dose constrain
sets. The data are fitted by linear regression (y = ax + b):
yset1 = 0.33x+35.7 (r = 0.66, dashed line), yset2 = 0.33x+
29.7 (r = 0.72, solid line) and yset3 = 0.35x+20.0 (r = 0.84,
dotted line)
the CTV-PTV margin with 1 mm results in an increment of the mean dose to
the parotid gland of approximately 1.3 Gy. Consequently, the NTCP decreased
for smaller margins. Decreasing for example the margin from 6 to 3 mm, without
compromising the homogeneity of the dose distribution in the lymph nodes, results
in a reduction of 20 % in NTCP, showing the benefit of reducing the margins.
The dose distribution has been analyzed for three different dose constrain sets,
resulting in: an optimal dose distribution in the PTV (set 1), optimal dose distri-
bution in the PTV while sparing the parotid gland (set 2) and more parotid gland
sparing but at the expense of the dose homogeneity (set 3). Using set 2 instead of
1, it is possible to reduce the dose to the parotid gland while the dose distribution
to the PTVs remains the same. Using set 3 it is possible to reduce the dose to the
parotid glands further, but part of the lymph node containing regions received a
lower dose compared to the calculations for set 1 and 2 (Fig. 4.3). This was the
case for all margins used. Although the NTCP could be decreased substantially,
for example for a fixed margin of 6 mm and using set 3 instead of set 2 the NTCP
was reduced from 0.44 to 0.28, these low dose regions might cause a lower TCP
for the lymph node containing regions. Using set 3 instead of set 2 might thus
have clinical consequences, not only for the NTCP but also for the TCP. When
reducing the dose to an OAR, the dose distribution within the target volumes
should be carefully monitored. It should therefore be investigated whether these
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low dose regions in the elective PTV are of high risk regarding local failure, before
dose reduction to the parotid glands using set 3 can be applied.
The mean volume of the parotid glands was 26.3 cm3 (range 22.4–31.0 cm3), which
is comparable to the mean value of 26.4 cm3 (range 12.9–46.4 cm3) reported in
literature (Roesink et al., 2000). Consequently, in this work no extreme volumes
of the parotid gland were studied. More extreme volumes of the parotid glands or
parotid glands which are located more caudal or cranial, probably show a similar
dependency of the mean dose on the margin. Since the mean dose depends on the
relative overlapping volume of the parotid gland, it might be different for a specific
margin. The mean dose of a more caudal located gland will be larger than a more
cranial situated gland.
The relation between the NTCP, calculated using data of Roesink et al. (2001),
and the margin is approximately linear (Fig. 4.5 a). This can be explained by
the fact that the slope of the NTCP curve is relatively smooth. The NTCP curve
of Eisbruch et al. (1998) is, however, steeper and has a lower TD50 (28.4 Gy)
compared to the data of Roesink et al. (2001). Therefore, the NTCP will increase
faster with increasing dose compared to the NTCP values calculated for the data
of Roesink et al. (2001).
The choice of a higher resolution of the fluence matrix might improve the steep-
ness of the dose gradient between the parotid glands and the PTVs and therefore
reduce the dose to the parotid glands. This will be investigated in the near future.
However, since the parotid glands are adjacent to the lymph node containing re-
gion, it is anticipated that they will still receive a substantial dose.
The use of less than seven beams for the IMRT treatment might reduce the com-
plexity of the IMRT plans. Less beams might however result, in less homogeneity in
the target volumes. Since the number of beams was not a optimization parameter
in this paper, a number of beams was chosen with acceptable dose homogeneity in
the target volumes. A detailed investigation of the effect of the number of beams
on the dose distribution will be reported in the near future.
Accurate delineation of the target volumes is important when using IMRT, since
the target volumes and OARs are adjacent to each other and a high dose is deliv-
ered to the target volumes. In this study we used CT images for the delineations
of the volumes. Other imaging modalities such as Magnetic Resonance Imaging
(MRI) might improve the delineation of various structures. MRI has, however, the
disadvantage of lack of electron density information, which is important for an
accurate treatment planning. In order to improve the delineation process CT-MRI
matching (Rasch et al., 1997) might be used, since this allows the simultaneous
use of both image modalities.
With the currently available positioning equipment it is possible to achieve a stan-
dard deviation of the systematic and the random error of 2 mm or less for head
and neck treatment techniques (Hurkmans et al., 2001b; De Boer et al., 2001).
With the use of correction protocols, the systematic error can be reduced to 1 mm
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(De Boer et al., 2001). Although it is often mentioned that accurate patient posi-
tioning during the treatment sessions is of crucial importance, margins which take
into account the systematic and random errors, are not always explicitly stated in
literature. For head and neck cases van Dieren et al. (2000), Eisbruch et al. (1998)
and Hunt et al. (2001) used a margin 5 , 5 and 10 mm respectively. Using our
conventional position verification tools, where anatomical structures are matched
using portal images, a margin of 6 mm will be used for head and neck patients. In
order to reduce the margin, and thus reduce the dose to the parotid glands, the
patient position has to be more accurate. Using stereotactic immobilization sys-
tems instead of the conventionally used head masks might improve the positioning
accuracy during the treatment. Stereotactic immobilization systems are however
usually patient unfriendly. Using dental casts the immobilization might also be
improved, this type of immobilization can however not be used for all patients.
At our department implanted gold markers (Nederveen et al., 2000, 2001a) are
used for daily position verification of the prostate and will eventually be used for
online position verification. The same approach will be used for the position ver-
ification for head and neck cases. The advantage of the use of markers compared
to the matching of anatomical structures is that the automatic detection of the
gold markers is accurate and fast. Especially for complex IMRT plans with seven
different beam angles, matching of anatomical structures will be more difficult
compared to the position verification using gold markers. Two orthogonal fields
might be added for position verification purposes. The adding of extra fields for
position verification is however in contradiction with the use of IMRT. Using the
gold markers for position verification it might be possible to reduce the margin to
3 mm. As has been shown in this study this may result in a NTCP reduction of
approximately 20 %.
4.5 Conclusion
The mean dose to the parotid gland decreased when smaller margins are applied
to the CTV for the IMRT treatment of the oropharynx. Reducing the margin with
1 mm results in an decrease of the mean parotid dose by approximately 1.3 Gy.
Therefore, more accurate patient positioning, resulting in smaller margins, results
in a lower NTCP for xerostomia.
For a fixed margin the dose to the parotid glands can be reduced, using a more
optimal dose constraint set for the parotid glands. The parotid glands, however,
will receive a substantial dose and eventually a compromise has to be made between
the dose in the lymph node containing region and the dose to the parotid gland.
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Abstract
Purpose: To assess the toxicity and reliability of the use of implanted gold markers for
position verification during the irradiation of head-and-neck cancer.
Methods and Materials: Ten patients with localized head-and-neck tumors received two
gold markers in the parapharyngeal region. The acute and late radiation related toxicity
were scored prospectively, using common toxicity criteria. The patients were immobilized
during irradiation using a five-point mask. The marker location was detected in portal
images taken with an a-Si flat panel imager. The intermarker distance as well as the
interfraction motion of the markers was determined for all patients.
Results: No acute major complications were observed. The acute toxicity grade was not
larger than normally detected. The markers were visible in all images. A small time trend
was observed in the intermarker distance for three patients. For these patients at least
one marker was located in the mucosa or pharyngeal constrictor muscle. Deeper seated
gold markers did not show a time trend in intermarker distance. The random positioning
uncertainty determined using the markers was on average 1.1 and 1.4 mm (1 standard
deviation) in the caudal-cranial and anterior-posterior direction respectively.
Conclusion: The use of implanted gold markers for position verification during radiother-
apy of head-and-neck patients seems safe and feasible. To avoid any chance of migration,
markers should be placed in deep muscular compartments.
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5.1 Introduction
In order to reduce geometric uncertainties during the treatment, patients treated
for head-and-neck cancer are usually immobilized using a mask. For position veri-
fication purposes, portal images can be taken during the treatment fractions using
an electronic portal imaging device (EPID) or mega-voltage films. Usually portal
images are taken of lateral and anterior-posterior fields. The internal bony struc-
tures visible within the portal image are then aligned with those in the reference
image (De Boer et al., 2001; Gilbeau et al., 2001; Hurkmans et al., 2001b). Random
and systematic errors of approximately 2 mm (1 standard deviation) have been
reported (De Boer et al., 2001; Gilbeau et al., 2001; Hurkmans et al., 2001b). A
disadvantage of this procedure is that the delineation and matching of bony struc-
tures is relatively time consuming. Furthermore, the projection of bony structures
can sometimes be difficult to interpret, especially when these structures are ro-
tated relative to the reference position and/or the field size is relatively small.
Instead of using anatomical landmarks, implanted gold markers can be used for
position verification (Crook et al., 1995; Vigneault et al., 1997; Alasti et al., 2001;
Shirato et al., 2000; Litzenberg et al., 2002; Dehnad et al., 2003). These markers
should not be too large, because large markers can result in more tissue damage.
The markers should, however, be large enough to be visible in a portal image taken
with an EPID. Using an a-Si flat-panel imager it is possible to visualize markers,
which have a size, a diameter of 1.0 mm and length of 5 mm, which is clinically
acceptable (Nederveen et al., 2001a). Although this approach is invasive, it has sev-
eral advantages. The markers can be detected easily within a portal image made
with 1-2 monitor units (MU; Nederveen et al. (2001a)) and the determination of
the three-dimensional coordinates of a marker is straightforward. Furthermore the
detection of the markers can be automated more easily. These advantages make
it possible to use marker-based position verification for daily on-line position cor-
rections. The use of markers instead of bony structures might also be useful when
applying IMRT, using multiple field angles and small segments.
The use of gold markers for positioning verification has been reported mainly for
the irradiation of the prostate and organs within the thorax or upper abdomen
(Crook et al., 1995; Vigneault et al., 1997; Dawson et al., 2000b; Nederveen et al.,
2001a; Alasti et al., 2001; Litzenberg et al., 2002; Shirato et al., 2000). Murphy
et al. (2000), used implanted markers for radiosurgery for the spine and pancreas.
In a study of Gall and Verhey (1993), the use of implanted radiopaque fiducial
markers was tested using a skull phantom. Although it was mentioned that the
technique was implemented for positioning patients for proton beam therapy, re-
sults of positioning accuracy in clinical practice have not been reported.
It was the purpose of this work, to investigate the use of implanted gold markers
for position verification during radiotherapy of head-and-neck cancer, and partic-
ularly the toxicity and reliability of this marker-based position verification. For
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Table 5.1: The original tumor site and TNM classification of the
tumor, the prescribe dose and the CTC score, for radiation
mucositis, direct after radiotherapy (t=0) and 8 weeks after
radiotherapy (t=8).
Patient Tumor site TNM stage Presr. Dose CTC
t=0 t=8
1 unknown primary TxN2cM0 50 2 0
2 glottis larynx T2aN0M0 70 3 0
3 larynx T2aN0M0 70 3 0
4 tonsil T3N2bM0 66 3 1
5 nasopharynx T1N2Mx 70 3 0
6 larynx T1N0M0 70 2 0
7 supraglottis larynx T4N0M0 66 2 0
8 oropharynx T2NxM0 69.5* 3 1
9 larynx T0pN2bM0 70 2 0
10 nasopharynx T4N2Mx - - -
*accelerated fractionation scheme
this purpose, markers were implanted in ten patients treated with conventional
radiotherapy. Their position was monitored during the treatment of these patients
using an a-Si flat panel imager.
5.2 Methods and materials
5.2.1 Patients
Ten patients with localized head-and-neck tumors (Table 5.1) received 2 fiducial
markers (Nederveen et al., 2001a). One patient refused radiotherapy after implan-
tation. Nine patients received 3-D conformal radiotherapy. For one of those patients
the treatment course was combined with chemotherapy. Patients were treated with
isocentric multi-field techniques including 6 MV lateral wedged beams. Customized
blocks or MLC were used to match the field shape to the target in beams-eye-view.
A five-points thermoplastic mask (PR5, Sinmed Radiotherapy Products, Reeuwijk,
The Netherlands) was used to immobilize the patient.
5.2.2 Marker implantation
The use of radiopaque markers for position verification during radiotherapy, has
been investigated for treatment of the prostate in our institute (Dehnad et al.,
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(a) (b)
Figure 5.1: A transversal slice of CT scan of two patients with im-
planted gold markers. For one patient the marker is located
in deep muscle compartments (a). For an other patient the
marker is located superficially (b). In order to prevent ar-
tifacts, the transversal slices are shown imaging the tip of
the markers.
2003). The radiopaque markers consist of a gold rod (1.0 mm diameter, 5 mm
length). The same markers have been used for this study. The markers were im-
planted in all patients under general anesthesia while undergoing their work up
panendoscopy. The implantation of the markers took approximately 5 min. An
Iodine-implantation needle with a homemade stopper was used to implant the
markers in the parapharyngeal region (Fig. 5.1). This stopper could be fixed to
the needle at any point from its sharp end to define the insertion depth. The diag-
nostic CT scan was used as a guide for the implantation. The stopper was placed
5 to 8 mm from its sharp end. For one patient the markers were placed deeper,
namely 40 mm. The patients did not receive prophylactic antibiotic.
5.2.3 Toxicity
All patients were asked to inform the physician as soon as they noticed the follow-
ing symptoms: fever, chills, intractable throat pain and bleeding. The acute and
late radiation related head-and-neck toxicity, radiation induced mucositis, were
scored in each patient prospectively, using Common Toxicity Criteria (National
Cancer Institute, 1999).
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5.2.4 Portal imaging
The portal images of all treatments fields were made with an a-Si flat-panel im-
ager (iView GT, Elekta Oncology Systems, Crawley, UK). The imaging area of
the panel is 26 × 26 cm2 at the isocenter, with a spatial resolution of 0.25 mm.
The imager is mounted on the gantry of a linac (SLi20, Elekta Oncology Systems,
Crawley, UK).
For each patient, the beam setup contained lateral beams for the first part of the
treatment (25 fractions). In order to compare the data of all patients, images were
taken during these fractions. On average, images were taken during 19 fractions
(range 10–25) for each patient. For patient 9, only 10 fraction were obtained. In
total, images were recorded during 173 treatment fractions. For each gantry angle
an image was taken of at least 100 MU, which was used for inter-fraction motions
analysis. High frequency intrafraction motions (van Asselen et al., 2003) are con-
sequently not influencing the data.
When marker-based position verification is used during an IMRT treatment, the
markers should be visible in images taken with a few monitor units. Images were
also taken with a small number of MU (approximately 4 MU).
The marker location in the portal images were detected using software developed
at our institution. This software is currently used for position verification during
the treatment of the prostate and is capable of automatic detection of the mark-
ers (Nederveen et al., 2001a; Dehnad et al., 2003). It is, however, also possible to
localize the markers manually. The reproducibility of the marker detection was ap-
proximately 0.2 mm (1 standard deviation), which was determined from repeated
analysis.
5.2.5 Marker migration
In order to achieve a high accuracy in position verification, the position of the
marker should not change relative to the surrounding tissue during radiotherapy.
For that reason markers should better not be implanted inside the tumor, which
might show regression during the treatment. This will result in displacement of
the markers relative to the anatomy of the patient.
The inter-marker distance can be used as an indicator for marker migration. Since
for all patients the lateral beams were used, the three-dimensional inter-marker
distances could not be determined. Instead, the projected inter-marker distance is
used to investigate the migration of the markers.
5.2.6 Rotations
The three dimensional coordinates of the markers could not be determined, since
only lateral beams were used. Therefore rotations could not be detected. Rotations,
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however, might cause changes in the projection of the inter-marker distance. In
order to estimate the effect of rotations on the inter-marker distance we simulated
rotations. After the patients underwent computer tomography (CT), the coordi-
nates of the markers were determined. The influence of rotation on the projected
inter-marker distance was determined using the spine as rotation axis.
5.2.7 Interfraction motion
The center of gravity of the position of both markers was determined for each
fraction in the lateral fields for all patients. The center of gravity is used in fur-
ther analysis of the setup errors. The displacements were calculated relative to the
reference positions of the patients, which was the position of the markers in the
patient during the localization procedure of the treatment. Although the number
of patients is small for this feasibility study the mean systematic error (M), the
standard deviation of the systematic errors (Σ) and the mean of the standard de-
viation of the random error (σ) were calculated.
To investigate the effect of position verification, an off-line position correction was
performed using a shrinking action level protocol (Bel et al., 1993). The running
average of the displacements was therefore calculated over the last number of Nmax
fractions. A correction is applied when this average exceeds a certain action level.
This action level shrinks when more fractions are delivered without corrections.
After correction, the action level it set to the initial value (α). The corrections were
performed for each direction separately. The correction parameters were Nmax =
4 and α = 4 mm.
In six patients, sufficient bony structures were visual in the portal images. For
these patients, the correlation between the position of the markers and the bony
structures was investigated using the portal images of 10 fractions per patient. The
bony structures, as well as the marker location was therefore determined, using
the iView-GT software.
5.3 Results
5.3.1 Marker detection
Using the a-Si flat-panel imager it was possible to obtain high quality portal images
of the head-and-neck region during the treatment. In all images, the location of
the markers could be determined. In order to test the visibility of the markers,
images were taken with low monitor unit exposure. Even in images obtained with
4 MU, the markers were clearly visible (Fig. 5.2).
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Figure 5.2: A portal image taken with approximately 4 monitor
units. The location of the markers is indicated with two
arrows.
5.3.2 Toxicity
We observed no acute major complications such as pain, bleeding or infection
by gold seed implantation. No rejection reaction by the seeds was observed and
there was no loss of seeds. The acute head-and-neck toxicity grade (Table 5.1) did
not differ from the expected aspects in head-and-neck tumors. At the follow up
examination there was no sign of foreign body reaction at the implantation site.
5.3.3 Marker migration
The projected inter-marker distances were calculated for each patient for all recorded
fractions. This resulted in nine lists of distances, on average consisting of 19 dis-
tances (range 10–24). A relatively small variation was observed in the projected
inter-marker distances (Fig. 5.3). The average standard deviation of the projected
inter-marker distance was 0.8 mm.
A linear regression analysis was performed to investigate migration of the mark-
ers. The data of six patients did not show a significant change in the projected
inter-marker distances (Fig. 5.3). For three patients, however, a correlation was
determined with a correlation coefficient (r) of 0.58, 0.67, and 0.66 for patient 3,
4 and 5 respectively. In these cases the projected inter-marker distance increased
during the treatment (Fig. 5.3 and Fig. 5.4). The magnitude of the increase was
0.06, 0.05 and 0.07 mm/day for patient 3, 4 and 5 respectively. For the overall
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(a)
(b)
Figure 5.3: The observed projected inter-marker distance (Dp)
during the treatment (Tp) of a patient without time trend
in inter-marker distance (a) and a patient with a time trend
(b).
treatment time of 30 days this would result in an increase of approximately 1.8
mm. The increase was mainly in the caudal-cranial direction. To evaluate the mi-
gration of the seeds, the parapharyngeal region was delineated in all CT scans.
Migration occurred, when at least one of the markers was implanted superficially
in the mucosa or pharyngeal constrictor muscle (Fig.5.5). No migration was deter-
mined for markers implanted in deeper muscle compartments, such as the longus
capitis, longus colli and scalene group (Fig. 5.5).
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(a) (b)
Figure 5.4: Two portal images of the same patient showing the
situation with maximum projected inter marker distance
(a) and minimum projected inter marker distance (b). The
location of the markers is indicated with two arrows.
5.3.4 Rotation
The rotations were simulated using the coordinates determined from the CT-scan.
For rotations of 5 degrees, with the spine as rotation axes, the projected inter-
marker distance could change up to 2.6 mm. On average, however, a rotation of 5
degrees resulted in changes in inter-marker distances of 0.9 mm (range 0.01 - 2.60
mm).
5.3.5 Interfraction motion
For each marker, the displacement relative to the marker in the reference image
was calculated. An example of the position of two markers relative to the reference
image is shown in figure 5.6. In order to determine the interfraction motions, the
center of gravity of both markers was calculated for each fraction and for all
patients. The markers of patient 3, 4 and 5 were included, because the marker
migration was relatively small and the center of gravity is less sensitive to time
trends. The values of the mean systematic error (M), the standard deviation of all
systematic errors (Σ) and the mean of the standard deviations of the random error
(σ) are similar for both directions (Table 5.2). The systematic error of patient 7
was large, and amounted to 4.4 mm and 3.8 mm in the AP and CC direction,
respectively.
Using the shrinking action level protocol for corrections of the patient position,
the standard deviation of the systematic errors decreased substantially (Table 5.2).
The average number of corrections was 0.7 in the anterior-posterior direction and
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D
S
Figure 5.5: The location of the implanted markers was divided
in two compartments, which are delineated in a CT image.
The superficial compartment (S) containing the mucosa of
pharyngeal constrictor muscle, and deeper muscle compart-
ments (D), such as the longus capitis, longus colli and sca-
lene group.
0.8 in the caudal-cranial direction per patient.
For six patients, the correlation between the location of the bony structures and
the marker location was investigated. On average, the correlation coefficient was
0.81 (range 0.71–0.97) in the anterior-posterior direction for both markers. For
the caudal-cranial the average correlation coefficient was 0.70 (range 0.24–0.95).
Especially for patient 5, the correlation was poor. The same patient showed a time
trend in the projected inter-marker distance.
5.4 Discussion
In this study, position verification using implanted gold markers was investigated
for head-and-neck radiotherapy. Gold markers were implanted in the parapharyn-
geal region. No acute major complications were observed after implantation. The
markers did not induce any additional toxicity. We therefore conclude that the
implantation of markers for position verification during the treatment of head-
and-neck cancer is a clinically safe procedure.
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(a)
(b)
Figure 5.6: The displacements of a marker relative to the refer-
ence position for the caudal-cranial (CC) and the anterior-
posterior (AP) direction for a fixed marker (b) and a marker
showing migration (b).
The projected inter-marker distance differed from day to day, with a standard
deviation of 0.8 mm, which is the result of detection accuracy, setup uncertain-
ties and migration. Besides rotations, random displacements of the patient can
also cause slight changes in the projected inter-marker distances. Small rotations
of 5 degrees around the spine may have caused differences in inter-marker dis-
tances of approximately 1 mm. For six patients, no significant change in the pro-
jected inter-marker distance during the treatment was observed, indicating that
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Table 5.2: The mean systematic error (M), the standard deviation
of the systematic errors (Σ) and the mean of the standard
deviations of the random error (σ) of 9 patients without cor-
rections and using a shrinking action level (SAL) protocol
for position corrections.
No correction SAL
AP CC AP CC
(mm) (mm) (mm) (mm)
M -0.5 0.0 0.0 0.2
Σ 1.6 1.9 0.5 0.6
σ 1.4 1.1 1.5 1.5
the marker position did not change systematically relative to the surrounding pa-
tient anatomy. Another indication that the marker position did not change is that
the determined random error was relatively small, on average 1.1 and 1.4 mm in the
caudal-cranial and anterior-posterior direction, respectively. Three patients showed
a small increase in the projected inter-marker distance during the treatment. For
each of these three patients, at least one marker was implanted superficially in the
pharyngeal mucosa or pharyngeal constrictor muscle. Radiation induced inflam-
mation of the mucosa might be an explanation for this increase, since the epithelial
component of the mucosa is prone to radiation induced inflammation. The correla-
tion between this effect and the grade of mucositis was, however, not studied. Any
swelling resulting from the acute reaction could increase the inter-marker distance.
Therefore to avoid any chance of migration, markers should be implanted deep in
the muscular compartment which is not prone to this phenomenon.
The random and systematic errors determined in this study were relatively small,
an amounted to 1-2 mm. The number of patients is, however, small and data
of more patients are needed to more accurately determine the setup errors. In a
review of Hurkmans et al. (2001b) random and systematic errors of respectively
1.6-4.6 and 1.1–2.5 mm (1 standard deviation) were reported for patient with head-
and-neck cancer. With the currently available equipment, a standard deviation of 2
mm for both random and systematic error can be considered good clinical practice
(Hurkmans et al., 2001b). Bel et al. (1995) used metal markers placed in a wax
mold of the outer ear for position verification. These were only used during portal
imaging in order to prevent radiation damage to the outer ear, approximately 8
fractions were imaged per patient. The treatments fields had to be adjusted to vi-
sualize the markers. The standard deviations, averaged over the three directions,
were equal to 1.8 and 1.4 mm for the distributions of the systematic and random
deviations, respectively (Bel et al., 1995). The reported random and systematic
errors are similar to our results.
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The shrinking action level protocol (Maes et al., 2002) used in this paper, was also
applied by De Boer et al. (2001) to their positioning verification data determined
for head-and-neck irradiation. Using a value of 2 for Nmax and an α of 4 mm their
observed systematic error reduced to 1 mm.
For some patients no bony structures are included in the treatment fields. In the
presented study, bony structures were not visible in the portal images of three pa-
tients. For these treatment fields implanted markers could improve the treatment,
since without them, position verification is hardly possible. For the treatment fields
including bony structures, the correlation between the marker location and loca-
tion of these bony structures was determined. In general the correlation was good,
especially in the anterior-posterior direction. For one patient the correlation was
poor. The same patient also showed a time trend in inter-marker distances, indi-
cating that at least one marker is loosely attached to the surrounding anatomy.
The markers and bony structures are not located at the same position in the pa-
tient. Projections of the markers and bony structures will be differently affected
by small rotations or displacements of the patient. For bony structures this can
result in small deformations compared to the projection on the reference image,
which results in less accurate position verification. In further studies the lateral
displacement should also be determined to exclude errors due to rotations.
The projection of the bony structures can be difficult to interpret when an arbi-
trary gantry angle is used, especially when the field size is relatively small. Extra
fields could be added for position verification purposes. This will however result
in an extra dose to the surrounding tissue, thereby creating a less conformal dose
distribution. Another approach to solve the problem of small fields, might be that
the portal images of each individual segments are added to obtain a larger area
which can be used for positioning verification (Fielding et al., 2002). The use
of markers instead of bony structures, however, makes the matching procedure
less complicated. Due to their high visibility and because the calculation of the
three-dimensional coordinates is straightforward, the detection of markers in small
segments for arbitrary gantry angles is relatively easy, and might therefore be use-
ful when using, for example, IMRT. The positioning verification procedure will
take little time, what makes it also suitable for on-line position verification.
5.5 Conclusion
The implantation of the gold markers did not result in increased toxicity for the
patient and the markers could be easily detected in all portal images. When the
gold seeds are not placed superficially, but in deeper muscular compartments such
as the longus capitis, longus colli and scalene group, their location did not change
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relative to the patient anatomy. The use of gold markers for position verification
for head-and-neck tumors seems feasible.
Chapter 6
Intrafraction motions of the larynx during
radiotherapy
This chapter has been published as
B. van Asselen, C.P.J. Raaijmakers, J.J.W. Lagendijk, C.H.J. Terhaard 2002 In-
trafraction motions of the larynx during radiotherapy International Journal of
Radiation Oncology Biology Physics 56 384–390
Abstract
Purpose: To quantify the intrafraction motions of the larynx during radiotherapy of la-
ryngeal cancer. Depending on the magnitude, duration and incidence, these motions may
have clinical consequences for the choice of margins around the clinical target volume.
Methods and Materials: The intrafraction motions were analyzed for 10 patients, treated
in 33 or 35 fractions. The intrafraction motions of the larynx were visualized using an
a-Si flat panel imager. Images were obtained every 200 ms, resulting in a movie of images
for each beam. In addition to visual analysis of all movies, the tip of the epiglottis was
delineated and used as a landmark, the coordinates of which were followed in time.
Results: Movies were obtained during 79% of the total number of radiotherapy fractions.
The total duration of swallowing was on average 0.45% (range 0.0 – 1.5) of the total
irradiation time. Deviations of motions other than swallowing, ranged between 0.3 and
11.5 mm. Some of these motions were more sudden, and others were probably related to
breathing, because the frequency of these motions was 8 – 20 per minute.
Conclusion: The incidence and total duration of swallowing is low. Therefore, it is not
necessary to apply an internal margin to take into account these displacements. Other
motions, however, occur more often. In 95% of the irradiation time the tip of the epiglot-
tis moves within a range of 7.1 mm. A margin should be applied to the clinical target
volume to take into account these motions.
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6.1 Introduction
During the irradiation of laryngeal cancer, patients are usually immobilized using
masks to reduce geometric uncertainties during treatment. These uncertainties are
caused by setup errors and organ motion and are taken into account by applying,
respectively, a setup margin and an internal margin (International Commission on
Radiation Units and Measurements (ICRU), 1999) to the clinical target volume
(CTV) on the basis of the magnitude of the deviations. The setup uncertainties for
head-and-neck cancer have been determined in several studies (Hurkmans et al.,
2001b; De Boer et al., 2001). Intrafraction organ motions are mainly studied for the
prostate and organs within the thorax and upper abdomonen (Nederveen et al.,
2002; Langen and Jones, 2001; Jaffray et al., 1999). The larynx is also a rather
mobile organ, and motion may occur from swallowing, breathing, or movement of
the tongue. Using videofluoroscopy to study liquid bolus swallows, deviations of
the larynx of 20–25 mm in the caudal-cranial direction and 3–8 mm in the anterior-
posterior direction were reported (Dantas et al., 1990; Jacob et al., 1989; Leonard
et al., 2000). The duration of swallowing for normal subjects is approximately 1 s
(Kendall et al., 2000; Hamlet et al., 1993). Although for head-and-neck cancer pa-
tients the swallowing function is worse compared with normal subjects (Pauloski
et al., 2000; Stenson et al., 2000), the swallowing time is still small compared with
the total irradiation time. Consequently, the incidence of swallowing is important.
In addiation to motion due to swallowing, other motion might occur during irra-
diation. Because both the larynx and the base of the tongue are attached to the
hyoid bone, tongue movement may result in displacement of the larynx. Inspiration
and expiration also causes displacement of the larynx. The displacement is small
during normal breathing and large during large inspiratory effort. Depending on
the magnitude, duration, and incidence, these motions contribute to the internal
margin, which is applied to the CTV.
Only recently, have techniques become available that can be used to detect internal
motion. Consequently no data are is available about the intrafraction motion of
the larynx. Using an a-Si flat panel imager (Nederveen et al., 2002) it is, however,
currently possible to visualize internal structures using a few monitor units (MU)
and observe and quantify intrafraction motion.
It was the purpose of this work to quantify the magnitude, duration and incidence
of laryngeal intrafraction motion during radiotherapy of laryngeal tumors. A better
understanding of these motions may lead to optimized treatment margins.
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6.2 Methods and materials
6.2.1 Patients
The intrafraction motion of the larynx was analyzed for 10 patients with varying
stages of laryngeal cancer (Table 6.1). All patients were treated with two lateral
6-MV opposing wedged fields. For most patients, 70 Gy (2 Gy/fraction five times
weekly) was prescribed at the isocenter. Three patients (Patients 5, 6 and 10; Table
6.1), received a dose of 66 Gy to the isocenter (2 Gy/fraction five times weekly).
The treatment fields were reduced after 25 fractions.
Before the start of treatment, patients were instructed not to swallow during ir-
radiation. A five-point thermoplastic mask (PR5, Sinmed Radiotherapy Products,
Reeuwijk, The Netherlands) was used to immobilize the patient. The mask was
fixated to the table at five positions, including positions near the shoulders.
Table 6.1: Original tumor site and TNM classification of tumor.
Patient. Tumor site TNM stage
1 Supra glottis T1NxM0
2 glottis T2N0M0
3 glottis T2N0M0
Supra glottis T1N0M0
4 Supra glottis T2N0M0
5 glottis T1aN0M0
6 glottis T1bN0M0
7 glottis T2N0M0
8 glottis T2N0M0
9 glottis T2N0M0
10 glottis TisN0M0
6.2.2 Flat-panel imager
An a-Si flat-panel imager (RID 256-L, EG&G Heimann Optoelectronics, Wies-
baden, Germany) was used for imaging the larynx during delivery of radiation.
The detector plate consists of 256 × 256 pixels, with a pixel pitch of 800 µm,
resulting in an imaging area of 20.48 × 20.48 cm. The imager was mounted on the
gantry of the linear accelerator (SL25, Elekta Oncology Systems, Crawley, UK)
with an in-house-made removable arm at a distance of 1.575 m from the focus of
the beam. This results in an imaging area of 13 × 13 cm2 at the isocenter and
a spatial resolution of approximately 0.5 mm. For accurate measurements of the
swallowing actions and other motions of the larynx, the panel operated with a
frame time of 200 ms. Each frame was taken with 1 – 2 monitor units.
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(a)
Base of tongue
Epiglottis
Vertebrae
Mandible
Air Trachea
(b)
Figure 6.1: (a) Example of a single portal image taken with a
frame time of 200 ms and (a) a schematic view of structures
within portal image (a).
Between 25 and 30 fractions were imaged for each patient. In total, images were
obtained during 272 of a total of 344 fractions, resulting in a >4.5-hour recorded
irradiation time. It was not possible to obtain images for all fractions of patients,
because the patients were not always treated on the linear accelerator on which
the flat panel could be mounted. In each fraction, two movies were obtained. Each
movie consisted of the consecutive frames (100 - 200 frames) obtained during the
delivery of one treatment portal. Because of the high image quality it is possible
to determine intra-fraction motions of several soft tissues, such as the epiglottis,
base of tongue and arytenoid (Fig. 6.1). Because of the different size of the treat-
ment fields for individual patients, not all soft tissues mentioned were incorporated
within the treatment field for each patient.
6.2.3 Analysis of larynx motions
The incidence of swallowing was detected by visual inspection of all movies. To
calculate the time of each swallowing action, a physician determined the start and
end of the swallowing action. The structures are in the same positions at the start
and end of the swallow, except for when the swallowing started before irradiation
began or ended after irradiation stoped. In those cases, the start and end were the
start and end points of the irradiation, respectively. The total time a patient was
swallowing was a summation of the time of each swallowing action. By calculating
the total recorded irradiation time of a patient, the percentage of time the patient
was swallowing could be calculated. Furthermore, the incidence as a function of
the treatment progress was determined. The treatment was therefore divided in
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periods of five treatment fractions. For the 3 patients with 33 fractions, the last
period included only three fractions.
To investigate the magnitude and duration of various motions, specific landmarks
were delineated in each frame of a movie. The resulting list of consecutive coordi-
nates of the landmark yielded two traces, one in the caudal-cranial direction and
one in the anterior-posterior direction. The best defined landmark was the tip of
the epiglottis (Fig. 6.1), for which the displacement could be determined in the
anterior-posterior and the caudal-cranial direction. In the treatment fields of 6 of
the 10 patients, the tip of the epiglottis was visible. For these patients, the tip
of the epiglottis was delineated in 10 movies during the first 25 fractions. This
analysis was done for movies containing no swallowing action to quantify the devi-
ations of motion other than that caused by swallowing. The first 25 fractions were
chosen, because the fields of the last 8-10 fractions were smaller and often did not
include the complete epiglottis. For each fraction, the peak-to-peak value (i.e. the
maximal displacement during one fraction) was calculated in both the anterior-
posterior and the caudal-cranial direction (A100). This value was also calculated
for 95% of the points closest to the mean coordinate (A95), that is, when 5 % of the
points, with the largest deviation from the mean, were excluded. The magnitude
of the motions for the other patients were determined by visual analysis.
6.3 Results
On average, movies were obtained during 79% of the total number of radiotherapy
fractions for a patient. Bony anatomy and various soft tissues could be visualized
in images of 1 – 2 monitor units (Fig. 6.1). In general, the quality of the images
was good, and motion of the larynx could be visualized (Fig. 6.2). In addiation to
the swallowing actions, various other movements could be observed. There was a
large discrepancy between the deviations and frequency of the larynx motion from
patient to patient. For some patients, only small deviations were determined (<1
mm), and for others, large deviations were seen (≤11.5 mm). Also, large variations
in the frequency of these deviations were observed.
The number of swallowing actions per patient, during the recorded irradiation
time, ranged from 0 to 26 (Table 6.2). Eight patients, however, swallowed between
0 and 3 times. Not all swallowing actions were complete, some started before the
beginning of irradiation and some ended after irradiation stopped. The time of
a complete swallowing action differed (range 0.8 – 6.3 s). On average, the total
duration of all swallowing actions was 0.45% (range 0.0 – 1.5 %) of the total
irradiation time recorded for a patient (Table 6.2).
The incidence of swallowing was also determined as a function of the treatment
progress. This analysis showed that most swallowing actions occurred during the
first five fractions (Fig. 6.3).
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Figure 6.2: Example of a swallowing action. Each following line
should be read from left to right. Images taken with a frame
time of 0.2 s (1-2 monitor units). Every third image is
shown, resulting in an interval time of 0.6 s between each
image.
In figure 6.4, a trace with a swallowing action is shown. The maximal displacement
during a swallowing action is difficult to determine, because at the point at which
the deviations are the largest, it is difficult to distinguish between structures. At
that phase, there is a lack of air between the base of tongue, epiglottis, arytenoid,
and pharyngeal wall, resulting in less contrast in that area. During swallowing the
displacements were >1 cm.
In 6 patients, the peak-to-peak values of the deviations of the tip of the epiglottis
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Table 6.2: Total number of swallowing actions, (Ns), the total
recorded irradiation time (Trec), total time patient swal-
lowed, (Ts) and ratio between the Ts and Trec.
Patient Ns* Trec Ts TsTrec ∗ 100
(s) (s) (%)
1 1 1355.4 0.2 0.01
2 0 1727.6 - 0
3 3 1291.5 11.0 0.85
4 9 1517.6 22.6 1.49
5 3 1960.0 4.6 0.23
6 26 2154.6 28.4 1.32
7 0 1622.8 - 0
8 2 1416.2 6.0 0.42
9 0 1566.0 - 0
10 3 1710.6 3.4 0.20
∗ complete and incomplete swallowing actions
Table 6.3: Peak-to-peak value of deviations of tip of epiglottis av-
eraged from 10 movies and range for cranial-caudal direction
and anterior-posterior direction for 6 patients.
Pat AP(mm) CC(mm)
A95 A100 A95 A100
1 0.9(0.5 - 1.4) 1.8(0.7 - 5.4) 0.8(0.3 - 1.2) 1.2(0.5 - 2.5)
2 1.2(0.6 - 2.1) 1.9(0.9 - 3.1) 1.8(0.6 - 3.5) 2.2(0.8 - 4.3)
3 3.0(1.4 - 4.7) 3.6(2.2 - 5.1) 4.2(1.4 - 6.8) 5.1(1.9 - 7.6)
4 2.8(1.9 - 4.6) 3.6(2.5 - 5.6) 2.5(1.4 - 4.6) 3.0(1.9 - 5.1)
8 3.4(2.0 - 5.2) 4.7(3.6 - 6.3) 5.7(3.4 - 7.1) 8.1(6.3 - 11.5)
9 1.1(0.7 - 2.1) 1.5(1.0 - 2.5) 0.9(0.3 - 1.9) 1.2(0.7 - 2.3)
Abbriviations: AP = anterior-posterior; CC = cranial-caudal; A95 = peak-to-peak
value for 95% of points closest to the mean values; A100 = maximal peak-to-peak
value.
Data presented as mean, with range in parenthese.
for 10 radiotherapy fractions were calculated (Table 6.3). The range of the A100
value was 0.7–6.3 mm for the anterior-posterior direction and 0.3–11.5 mm for
the caudal-cranial direction. The A95 value was on average 27% (range 0 - 75%)
and 24% (range 0 - 67%) smaller than A100 for the anterior-posterior and caudal-
cranial directions, respectively. The magnitude of the deviations for patients 5 and
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Figure 6.3: Incidence of total number of swallowing actions dur-
ing the treatment. Treatment divided into periods of five
fractions.
7 was approximately 2-3 mm and for patients 6 and 10 was approximately 5-8 mm.
Some typical examples of traces of the tip of the epiglottis are shown in figure 6.4.
Some movies showed a regular motion of the epiglottis, with a frequency between
8 and 20/min. For other patients, almost no motion was observed; however, an
instant deviation could occur.
6.4 Discussion
The maximal displacement of the larynx caused by swallowing is large (>20 mm)
in the cranial-caudal direction (Dantas et al., 1990), which could have implications
for the dose distribution in the target. The incidence during irradiation is, how-
ever, low for most patients. On average, 0.45% of the irradiation time, a patient
was swallowing, with a maximum of 1.5%. The effect on the dose distribution
was even less, because during this period, the larynx is not always in its maxi-
mal position. Swallowing has therefore, a small effect on the dose distribution in
the target volume. Also, because the effect is small, it may not be necessary to
adjust the internal margin to take displacements due to swallowing into account.
The treatment time for the technique used at our department was <1 minute;
for longer treatment times, the swallowing incidence will increase (Hamlet et al.,
1993). In such cases, for example, when using intensity-modulated radiotherapy,
the impact on the dose distribution might be larger. Hamlet et al. (1993) reported
a swallowing incidence of 0.27 per irradiation interval for intervals of <2 minutes.
In their study, a close-up view of the patient’s throat with the console monitor
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(a)
(b)
(c)
Figure 6.4: Three examples of deviation of tip of epiglottis: (a)
frequent motion of tip of epiglottis, (b) sudden deviation at
end of fraction, and (c) irregular motion with swallowing
action.
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video camera was used to visually identifying a swallowing action. They could
not, therefore, measure the duration time of the swallowing actions. Patients were
not instructed not to swallow but to breath normally in that study.
Although it is not necessary to take into account deviations due to swallowing,
care should be taken when reducing the margins. Irradiating an inhomogeneous
region, due to the trachea, with too-small fields might result in a lack of lateral
electron equilibrium (Martens et al., 2002).
The swallowing times in our study were longer than those reported in the liter-
ature (Kendall et al., 2000; Hamlet et al., 1993). The difference may have been
caused by the definition of the duration of a swallowing action. In studies on timing
events for normal swallowing, a bolus is followed in time; however, in our study,
the displacement of the larynx was determined during swallowing without a bolus
(saliva only). In our definition, all structures should be in similar position at the
beginning and end of the swallowing. It has also been shown that the swallowing
function for patients with head-and-neck cancer is worse compared with healthy
subjects (Pauloski et al., 2000; Stenson et al., 2000). This may also explain the
differences with swallowing times in normal subjects.
Most swallowing actions did occur within the first period of treatment (i.e. the
first five fractions). This might have been because by the fact that most patients
are nervous during the first few fractions. At the end of the treatment, during the
last period, the incidence of swallowing seemed to increase. This might have been
caused by thick saliva and/or radiation-induced mucositis.
The displacement of the tip of the epiglottis differed from patient to patient. The
largest displacements were seen in the caudal-cranial direction (range 0.5 – 11.5
mm). In the anterior-posterior direction, the displacements were smaller (range
0.5 – 6.3 mm). Because most motions occur with a frequency of 8–20/min, these
are probably associated with breathing. The nervousness of a patient might cause
heavy breathing, and for large inspiratory effort, the excursion is large. The ner-
vousness of a patient also might be the cause of the differences between patients,
assuming a nervous patient shows more activity than a more relaxed patient. The
differences between A100 and A95 differed for each patient. When the difference
was large, this was probably caused by a sudden movement of the epiglottis (i.e.,
on average, the motion of the epiglottis is much smaller than the maximal peak-
to-peak value would imply). For some patients, the A100, as well as the A95, is
large. Therefore, the margins to the target volume should be adjusted to take into
account these motions, because it is not known whether a patient will shown a lot
of organ motion before the start of treatment. During 95% of the time, the devia-
tions were within 7.1 mm and 5.3 mm in the caudal-cranial and anterior-posterior
direction, respectively. To accomplish a full coverage during 95% of the time the
margin to the CTV would than be approximately 3.5 mm in the caudal-cranial
direction and 3 mm in the anterior-posterior direction, assuming that the image
used for delineation is the average position. For 99% of the time, all deviations
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were within 10.5 mm and 5.9 mm in the caudal-cranial and anterior-posterior di-
rection, respectively.
6.5 Conclusion
Although the displacement of the larynx due to swallowing can be large, the inci-
dence is low for most patients (on average 0.45% of the irradiation time). Therefore,
there is no need to adjust the margins around the CTVs to take into account these
displacements. Other motions occur with a magnitude smaller than that caused by
swallowing. In the cranial-caudal direction, the tip of the epiglottis moves within
a range of 7.1 mm 95 % of the time. These motions can occur often and a margin
should therefore be applied to the CTV to take these motions into account.

Chapter 7
General discussion
7.1 Introduction
In this thesis intensity-modulated radiotherapy was applied to breast and head-
and-neck cancer. In chapter 2 an IMRT technique was developed for irradiation
of the breast. A highly conformal dose distribution with a single dose level to the
target was obtained. A form of dose painting was achieved for the IMRT irradia-
tion of oropharyngeal cancer. The aim of this treatment was to deliver three dose
levels to the target volumes while sparing the normal tissues (chapter 3 and 4).
For accurate delivery of the dose distribution, resulting in reduction of the margins
needed for geometric uncertainties, the use of gold markers for position verifica-
tion was investigated for head-and-neck irradiation. Beside interfraction motions,
intrafraction motions were determined in the head-and-neck region.
In the next section image-guided IMRT will be discussed in general. A more de-
tailed discussion about the use of IMRT and its implications for breast cancer and
oropharyngeal cancer are presented in sections 7.3 and 7.4 respectively.
7.2 Image-guided IMRT
Images providing anatomical and biological data should be available to obtain
the ideal radiotherapy plan (Ling et al., 2000). In this thesis CT images are used
to visualize the patient anatomy. Using CT scans, electron density information
is available, which is needed for accurate dose calculations. Targets volumes and
surrounding organs at risk are delineated within the CT images. Accurate delin-
eation of volumes of interest becomes a mayor issue when delivering highly confor-
mal plans with IMRT. When the actual target is larger than the delineated target
volume, this results in underdosage in the target and can result in a reduction in
TCP. On the other hand, when the actual target is smaller than the delineated
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target, this may have consequences for the dose to the surrounding tissues. The
uncertainties in delineation should be taken into account during the planning pro-
cess. In order to estimate the uncertainties and improve the delineation process,
delineation studies are essential. The simultaneous use of different imaging modal-
ities, such as CT, MRI, or PET, could improve the delineation process, because
the advantages of each separated imaging modality can than be combined. The
advantage of MRI is that it can be used to visualize soft tissue. Several studies
reported the used of MRI for delineation of various cancer sites (Rasch et al., 1997,
1999; Weltens et al., 2001; Nishioka et al., 2002; Parker et al., 2003; Ten Haken
et al., 1992). PET has shown to be helpful in detecting lymph node metastases for
lung cancer (Marom et al., 1999; Gould et al., 2002), for the head-and-neck cancer
the use of PET for that purpose is still controversial (Nishioka et al., 2002). PET
can also be used to determine the boundaries of primary tumors when there are
inflammatory changes around the tumor (Nishioka et al., 2002). The combined use
of these techniques should be investigated. Image fusion, the 3D matching of each
image data set, is then of crucial importance.
Using the anatomical data of the CT, the three-dimensional dose distribution can
be calculated by inverse planning based on dose constraints assigned to the delin-
eated volumes (chapter 3 and 4), or directly by using the CT three-dimensional
geometrical information (chapter 2). The use of biological data for treatment plan-
ning is still under development and is not used for treatment planning in this thesis.
Instead, the clinical starting points, i.e. the prescribed dose to the targets and the
tolerance dose of the organs at risk, were based on clinical studies applying ho-
mogeneous dose distributions. Tumor characteristics, such as tumor cell density
and radiosensitivety, however, are not homogeneously distributed throughout the
target. The use of image modalities such as PET, SPECT and MRI, providing
functional information of the tumor, should therefore be investigated. Using this
information it might be possible to improve the TCP by applying a heterogeneous
dose distribution based on tumor characteristics.
During radiotherapy, the position of the target should be the same as during the
imaging process needed for the treatment planning. In this thesis the use of EPIDs
has shown to be a useful tool to determine inter- and intrafraction motions (chap-
ter 5 and 6). Although gold markers can be used for position verification purposes,
there is lack of anatomical information during radiotherapy. Due to radiotherapy,
the shape and size of the anatomy might change. In order to improve the quality
of the treatment, a replanning using the actual size and shape of the target vol-
ume and the surrounding normal tissue could be considered. Other techniques are
than needed to visualize the position as well as the shape and size of the target
volume. A possible way to visualize the target during radiotherapy is the combina-
tion of a linear accelerator and a CT scanner as developed in tomotherapy (Mackie
et al., 1999). Jaffray and Siewerdsen (2000) developed a cone beam CT scanner, by
mounting an X-ray source in combination with a flat panel imager on the gantry
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of a linear accelerator. By rotating the gantry a CT scan is acquired. A mobile
ultrasound-based targeting system (BAT) has been used for daily verification of
the position of the prostate (Lattanzi et al., 2000). Pressure of the ultrasound
probe can, however, cause a shift in the prostate location itself (Van den Heuvel
et al., 2002), resulting in less accurate position verification of the prostate. The
above mentioned systems allow visualization of the soft tissues just before each
treatment fraction. An other possible system is proposed by Lagendijk and Bakker
(2000). The integration of a linear accelerator and a MRI imager should result in
the imaging of soft tissues during radiotherapy.
7.3 Breast cancer
2-field IMRT
Using the three-dimensional geometry of the breast, an IMRT technique was de-
veloped (chapter 2). The technique was based on the division of the treatment
field in segments with similar equivalent path length through the breast and aims
to deliver a homogeneous dose distribution. Several other techniques have been
developed based on radiological thickness and transit dosimetry information from
EPIDs (Donovan et al., 2000; Lo et al., 2000). In a study of Kestin et al. (2000),
segments were designed from isodose surfaces calculated from an open tangential
beam. Using these techniques 80% to 90% of the dose is delivered by an open field
and 3-8 additional fields are added to create a homogeneous dose distribution.
Using a simple dose model Chui et al. (2002) presented a technique where the
optimum intensity is obtained by equalizing the dose to the midpoint of pencil
beam segments. Others groups used an inverse-planning algorithm, based on dose
constraints assigned to delineated volumes, to optimize the dose homogeneity in
the breast (Hong et al., 1999; Chang et al., 1999; Hurkmans et al., 2002; Thilmann
et al., 2002). Due to the inhomogeneity of the lung, the missing tissue effect and
oblique incidence, accurate dose calculation is rather difficult and advanced dose
models are required. Dose models used for inverse planning are usually simple
compared with models used for conventional three-dimensional planning, in or-
der to achieve acceptable calculations times for the optimization process. This
resulted in a significant discrepancy between the dose calculation performed with
the 3D planning model and the inverse-planning model used at our department.
The inverse-planning module is therefore not used for IMRT for breast cancer until
more advanced dose models are incorporated in the inverse-planning module.
Most mentioned studies used conventional beam arrangements, i.e. two tangential
fields. Using a four-field technique Landau et al. (2001) showed increased dose
homogeneity and significant improvement in heart sparing compared to conven-
tional techniques. This resulted, however, also in increased dose to the contralateral
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breast, resulting in an increased risk of radiation induced cancer in the contralat-
eral breast (Boice et al., 1992). A six-field arc technique resulted in poorer results
than conventionally achieved. Ma et al. (2003) reported that 2-field IMRT could
reduce dose to the lung, heart and contralateral breast compared to conventional
techniques. Multiple beam angle IMRT resulted in low dose regions in the nor-
mal tissues. Furthermore, it was concluded that modulated-electron radiotherapy
resulted in high conformal dose distributions. Irradiation with electrons can, how-
ever, cause a high skin dose. Li et al. (2000) showed for a combined electron and
IMRT technique improvement over the conventionally used tangential fields with
reduced dose to the ipsilateral lung and heart dose. A 9-field technique showed sim-
ilar results for the target coverage, but resulted in increased dose to other normal
structures. Thilmann et al. (2002) calculated IMRT plans for various combinations
of beams and intensity levels using inverse planning. The optimum treatment plan
for a left sided breast consisted of 12 beams using 7 intensity levels. The results
were not compared with a 2-field technique, the heart and lung did, however, re-
ceive a substantial dose. Overall the two field IMRT techniques seem to have the
most benefits. Due to the use of a simple beam geometry, the dose to surrounding
normal tissue can easily be avoided, similar to the conventional tangential fields.
Till now, the clinical implementation of three techniques have been reported (Lo
et al., 2000; Yarnold et al., 2002; Vinici et al., 2002). All techniques use a two-field
approach and a relatively simple segmental IMRT technique to optimize the dose
distribution (Donovan et al., 2000; Kestin et al., 2000; Lo et al., 2000). Yarnold
et al. (2002) reported that the early results of a randomized trail of standard ra-
diotherapy versus IMRT suggest that reduction in unwanted dose inhomogeneity
impacts on clinically observable late breast changes.
Position verification
The IMRT technique presented in chapter 2 delivers 88 % of the dose with an
open field containing the entire breast. The technique is therefore relatively insen-
sitive to organ motion and setup errors and no differences compared to conven-
tional treatment must be taken into account. The same margin was therefore used
as conventionally applied for geometric uncertainties. Using a similar segmental
IMRT technique as presented in chapter 2, Hector et al. (2000) showed that, al-
though the IMRT treatment was more susceptible to patient movement, it was still
superior compared to the standard treatment when considering the dose outside
95-105%. Studying the effect of intrafraction motion for dynamic IMRT, George
et al. (2003) found no statistically differences between the planned and expected
dose distributions.
As reported by Fein et al. (1996) and Lirette et al. (1995) portal images can be
used for position verification for breast irradiation. The effect of normal respiratory
function was thereby smaller than the effect of interfraction motion. A similar tech-
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nique can be applied for the IMRT technique due to the use of an open field with
similar size as conventionally used. Position verification might reduce the margin
and therefore reduce the dose to the heart and lung. An improved breast board
may also result in better reproducibility of the patient, and reducing the inter-
fraction motion. For further improvements of the reproducibility, active breathing
control (Wong et al., 1999) could be applied. Beside improving the reproducibility,
the separation between the chest wall and the heart is increased during deep inspi-
ration. Sixel et al. (2001) showed that the deep inspiration breath hold technique
has the potential to reduce the irradiated heart volume, and could be considered
for clinical introduction.
Target delineation
For analysis of the breast, the PTV and the lungs were delineated. Lead wires were
used to visualize the conventional field borders on the CT scan. In contradiction
with the use of the inverse planning software used in chapter 3 and 4, the delin-
eation of the PTV and the lung is not necessary for treatment planning. Using the
2-field IMRT technique presented in chapter 2, only the conventional field borders
are required. Therefore, the introduction of the technique will not require extra
time for delineation. Using the conventional field borders, many patients have been
successfully treated. To achieve a more conformal dose distribution, however, de-
lineation might be useful. Using the MLC, the field can be shaped around the
target in order to prevent dose the lung and heart. Inter- and intra-observer vari-
ation in the delineation of the breast on CT scans can be rather large (Hurkmans
et al., 2001a; Pitka¨nen et al., 2001). Differences between the breast parenchyma
and fatty tissue can be difficult to distinguish. Detailed delineation protocols are
therefore necessary for delineation of the breast for clinical practice.
Extensions to 2-field IMRT
In literature, the planning studies aim at a homogeneous dose distribution in the
whole breast, an extra dose to the tumor bed is thereby not included. A large
number of patients, however, receive this extra boost dose. The extra fields used
to deliver the boost dose can result in an extra dose to the lung and heart. Integra-
tion of the boost in the IMRT technique would therefore be useful. The complexity
of the geometry thereby increases and a simple form of dose painting is performed
with two dose levels. In order to achieve a conformal dose distribution with two
dose levels, the use of extra non-opposing tangential fields is probably unavoidable.
This will also result in some extra dose to surrounding normal tissues. It will be
difficult to incorporate the boost in the technique presented in chapter 2, because
it is based on the equivalent path length and tends to achieve a homogeneous
dose distribution. The aim of an integrated boost technique is, however, two level
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dose painting. An inverse planning system similar to that used in chapter 3 might
be useful. This is, however, currently not possible for clinical practice due to the
simple dose model used for inverse planning.
An other extension of the 2-field IMRT technique is the integration in the mul-
tiple field techniques used to irradiate the axillary, supraclavicular and internal
mammary nodes for breast cancer patients with positive lymph nodes. The tech-
nique presented in chapter 2 can be integrated in the multiple field technique used
at our department (Lagendijk and Hofman, 1992). It can also be use to improve
the match line between the tangential fields and the parasternal field. These con-
ventional fields might, however, also be improved in the future using conformal
radiotherapy. The anatomical boundaries of the regional lymph node target vol-
umes should therefore be investigated (Dijkema et al., 2003). Cho et al. (2002)
compared different radiotherapy techniques, including IMRT, for the irradiation
of the breast and upper mammary nodes. IMRT showed the best target coverage.
The lowest NTCP values for heart and lung were found for the IMRT technique
and a technique using oblique electron fields. Remouchamps et al. (2003) reported
that moderate deep inspiration breath hold significantly reduces heart and lung
doses when deep tangential fields are used for locoregional irradiation of the breast.
The dose homogeneity was improved using IMRT, while the dose to the heart was
slightly reduced.
7.4 Head-and-neck cancer
Segmental IMRT technique for oropharyngeal cancer
A segmental IMRT technique was developed for the irradiation of oropharyngeal
cancer. Beside the ability to reduce the dose to the normal tissues, such as brain,
spinal cord and parotid gland, and creating highly conformal dose distributions,
IMRT was used to apply a simple form of dose painting. The aim was to deliver
three different dose levels: one to the CTV of the lymph nodes, one to the CTV
of the primary tumor and one to the GTV of the primary tumor. The different
dose levels were simultaneously delivered in 30 fractions, resulting in a simulta-
neous integrated boost strategy (Mohan et al., 2000). Like Mohan et al. (2000),
we used an isoeffect relationship based on the linear-quadratic model to design
IMRT fractionation strategies. Care should be taken when designing a fraction-
ation strategy when delivering multiple dose levels simultaneously. Low fraction
doses result in long treatments. High fraction doses can result in short treatment
duration but also in an increased risk of injury to the embedded normal tissue.
Until late complications (Withers et al., 1995c; Maciejewski et al., 1989) of the
IMRT fractionation strategies are evaluated, care should be taken when escalating
the dose. For the clinical introduction we therefore started with an increase of 3
7.4. Head-and-neck cancer 93
Gy to the GTV.
Due to the complex geometry of the volumes of interest, most groups used an
inverse planning algorithm based on dose constraints to volumes of interests to
develop an IMRT technique for oropharyngeal cancer. Studying the effect of the
use of positioning margins for the parotid gland, Manning et al. (2001) used a
dynamic IMRT technique and nine beams for the irradiation of two oropharyn-
geal tumors. Vineberg et al. (2002) reported that sparing of the parotid glands is
possible without compromising target dose homogeneity for irradiation of oropha-
ryngeal cancer. Using nine beams, their optimized fluence profiles were deliverable
with either segmental or dynamic IMRT. It was, however, not clear whether the
dose was calculated using the deliverable segments or using the optimized fluence.
Only Wu et al. (2000) did show data, although not quantitative, that supported
the choice of nine beams for the irradiation of three head-and-neck tumors, includ-
ing an oropharyngeal case. Chao et al. (2000) used tomotherapy-based IMRT for
the irradiation of oropharyngeal cancers.
For segmental IMRT, the total number of segments is an important factor, since
the treatment time is closely related to the total number of segments. As presented
in chapter 3, the dose homogeneity correlated with the total number of segments.
For clinical introduction, approximately 100 segments were used. More segments
will result in too long treatment times (> 25 min.). The total number of segments
is determined by the number of beams and the number of segments per beam. Min-
imizing the number of beams without reduction of the quality of the treatment
would be useful. This might be achieved by applying beam orientation optimiza-
tion (Pugachev et al., 2001). The saturation level, for dose homogeneity in the
target volumes, might than be reached using fewer beams. It could, however, also
result in more segments per beam to achieve the same dose homogeneity similar
to the findings of chapter 3. Beam optimization might result in better sparing of
organs at risk adjacent to the target volumes. Chapter 3 shows that the five-beam
plans result in a lower dose to the parotid gland than other beam geometries.
Although beam orientation optimization might improve the treatment, it is still
hampered by long computing times needed for the optimization process (Pugachev
et al., 2001; Rowbottom et al., 2001). Another way to achieve fewer segments is
to optimize the sequencing process. Different segmentation methods can result in
a different amount of segments (Potter et al., 2002). In chapter 3 and 4 the opti-
mized fluence is divided into equidistant levels. Another division of the optimized
fluence might also result in fewer segments. If, for example, the minimum monitor
units delivered by one beam is 50 % of the total, this 50 % could be delivered
in one segment instead of five in case the fluence is divided in 10 levels. Another
method to reduce the number of segments is profile smoothing.
For the dose calculations in chapter 3 and 4 a bixel resolution of 1 cm × 1 cm is
used. The use of a higher bixel resolution might improve the dose distribution. For
a simple “C”-shaped target volume, Shepard et al. (1999) reported an increase in
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dose homogeneity for higher bixel resolution. For the 3D irradiation of the prostate
Kubo et al. (1999) showed more sparing of the rectum and bladder when using
a micro-multileaf (1.7-3 mm leaf width) instead of a normal MLC with 10 mm
leaf width. Beside the ability to improve the blocking of the surrounding normal
tissue using a higher resolution, it might be easier to deliver a heterogeneous dose
distribution using a higher resolution. A higher resolution can result in a better
sampling of the target volume, resulting in more degrees of freedom to deliver a
dose to an individual part of the target volume. In the direction of the leaf motion,
the resolution can be easily adjusted by choosing a smaller leaf step size, in the
opposite direction the resolution is limited by the leaf width. In order to achieve a
higher spatial resolution micro-multileaf collimators have been constructed, with
leaf widths projecting in the isocenter between 1.6 and 4.5 mm (Cosgrove et al.,
1999; Schlegel et al., 1992). The disadvantage of these systems is the limited field
size. Other attempts to increase the resolution are the use of two superimposing
MLC fields with a small shift in isocenter (Galvin et al., 1996) or a collimator
rotation (Evans and Partridge, 2000; Otto and Clark, 2002; Alfredo and Siochi,
2000). Topolnjak et al. (2003) reported a design study for a six-bank multi-leaf
collimator, which has a resolution comparable to the micro-multileaf collimators
and a field size of at least 40 cm. Bortfeld et al. (2000) utilized the methods of
sampling theory and the theory of linear systems in an effort to identify the opti-
mum leaf width. For a 6-MV beam this resulted in a minimum leaf width of 1.5-1.8
mm. Although a high resolution of the fluence matrix may have some advantages,
the disadvantage for segmental IMRT is that it can result in more segments.
Parotid gland
The parotid glands are located adjacent to the lymph node containing target vol-
ume. Therefore it is rather difficult to avoid irradiation to the parotid glands,
without reduction of the TCP. To achieve the prescribed dose in the lymph nodes,
a dose gradient outside the PTV, thus partially in the parotid glands, is necessary
to allow dose build up. Reduction of parotid dose could result in lower dose regions
in the lymph node containing region (chapter 4), i.e. moving the dose gradient into
the lymph node containing region. It should be investigated whether these lower
dose regions result in an increased risk regarding local failure. Furthermore, the
margin taken into account for position verification will result in an increased dose
to the parotid gland (chapter 4). Dose reduction can therefore also be achieved by
accurate position verification. Using the data of the marker based position verifi-
cation (chapter 5) as input for the recipe of Van Herk et al. (2000), a margin of
approximately 3 mm is determined. When decreasing the margin from 6 mm to
3 mm for moderate sparing of the parotid glands, the mean dose to the parotid
gland reduces by approximately 4 Gy corresponding with a decrease in NTCP for
xerostomia from 44 % to 35 %.
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In order to decrease the dose to the contralateral parotid gland, the cranial border
to which the contralateral lateral lymph nodes are irradiated might be lowered
(Eisbruch et al., 1998). In a recent study of Braam et al. (2003), it was shown that
for a groups of N+ patients metastatis of oropharyngeal cancer rarely appear high
cranially on the contralateral side, indication that the probability for microscopic
metastasis in that area in N0 patients must be small. Lowering the cranial border
of the lymph node containing area from C1 to C2 level II results in a decrease in
mean dose to the parotid gland of approximately 6 Gy (Astreinidou et al., 2003).
The NTCP did thereby decrease by approximately 12 %. These results are cur-
rently clinically used.
Delineation of volumes
In order to deliver highly conformal dose distributions with different dose levels,
accurate delineation of all volumes involved is necessary. Recent articles have re-
viewed the normal anatomy of the neck (Wijers et al., 1999; Nowak et al., 1999;
Gregoire et al., 2000). These were mainly focused at the delineation of the lymph
node regions or levels in the normal neck. Guidelines are provided for the delin-
eation of the electively treated lymph nodes. For the target volumes, the delin-
eation relies on historical information from surgical pathologic experiences. Few
studies reported the delineation of oropharyngeal tumors. In a study of Nishioka
et al. (2002) was reported that image fusion between 18FDG-PET and CT/MRI
was useful in GTV and CTV determination for oropharyngeal cancer. Rasch et al.
(1997) reported that MRI-derived GTVs were smaller and had less interobserver
variation than the CT-derived GTVs for advanced head-and-neck cancer. A pilot
study is started at our department to investigate the use of PET for target delin-
eation of head-and-neck tumors.
Beside the target volumes, also organs at risk should be accurately delineated. The
delineation of the brain and the spinal cord is relatively easy, because these organs
are enclosed by bony structures. The parotid glands is delineated on CT scans,
the use of MRI might be more accurate due to the ability of imaging soft tissues.
There are however no delineation studies concerning these normal tissues.
Position verification
Due to the complex geometry and high fraction doses, accurate position verifica-
tion is essential for head-and-neck tumors. High doses should be delivered to the
targets, while the dose to the brain and spinal cord should be minimized. A low
dose to the parotid gland is also important to improve the quality of life after ra-
diotherapy. As shown in chapter 4 one way to achieve this aim is accurate patient
positioning. Position verification of head-and-neck tumors is usually performed by
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applying an EPID or a megavoltage film (Hurkmans et al., 2001b). The position
of bony structures is thereby measured relative to a reference position. In a review
of Hurkmans et al. (2001b), a standard deviation of the systematic error of 1.6-4.6
mm and a random error of 1.1-2.5 mm (1 standard deviation) was reported for
the head-and-neck region. In chapter 5 markers were used for position verification
purposes. Markers are more easy to detect compared with bony structures, and
the determination of the coordinates is straightforward. Regarding IMRT, marker-
based positioning verification is especially useful due to the small fields used for
segmental IMRT with non-conventional gantry angles. When the marker is im-
planted inside a relatively mobile organ like the prostate (Dehnad et al., 2003), it
can be used to remove the systematic errors, while using bony structures this is
not possible.
Beside interfraction motions, intrafraction motions should be evaluated since these
can contribute to the margins taken for setup uncertainties. In the head-and-neck
region, intrafraction motion can be caused by organ motions, such as swallowing,
breathing, or tongue motions (chapter 6). Due to the low incidence, swallowing has
a minor influence on the dose distribution (chapter 6). Most organs in the head-
and-neck region are, however, relative immobile and attached to bony structures.
Intrafraction motion may also occur due to patient movements or relaxation of the
muscles. This might become an issue for IMRT treatments with long treatment
times and result in an unstable position relative to the start of the irradiation. The
delivery of an IMRT treatment plan can take 20 minutes. Markers could be used
to quantify the intrafraction motion, by taking multiple images during a single
fraction. When the determined intrafraction motions are large during long treat-
ments, it could be investigated whether marker-based position verification should
be applied during the treatment. This could reduce the margin taken for geometric
uncertainties.
7.5 Conclusion
Two different segmental IMRT techniques have been developed in this thesis for
respectively irradiation of the breast and the oropharynx. Both techniques have
been implemented clinically. Various other improvements can be applied as have
been discussed in this chapter. Part of them, concerning position verification for
head-and-neck cancer, have been investigated in this thesis.
Summary
In this thesis, intensity-modulated radiotherapy is applied to the irradiation of
breast and oropharyngeal cancer. Furthermore, interfraction and intrafraction mo-
tions are studied for head-and-neck cancer to further improve the treatment. In
the following paragraphs the results are summarized per chapter.
In chapter 2 an IMRT breast technique is developed taking into account the com-
plex three-dimensional geometry of the breast. The aim was to achieve dose ho-
mogeneity throughout the entire breast. The IMRT technique was based on the
division of the tangential fields in four multi-leaf collimator shaped segments. The
shape of these segments was obtained from an equivalent path length map of the
irradiated volume. Approximately 88% of the dose was delivered by two open
fields covering the whole treated volume. In a planning study including 5 patients,
the dose homogeneity improved for the IMRT technique was compared with the
conventional technique. The dose homogeneity in the PTV was 9.0% (range 6.4–
11.4%) for the conventional and 7.6% (range 6.5–10.3%) for the IMRT technique.
The mean lung dose was reduced for the IMRT technique by approximately 10%
compared with the conventional technique. Beside the improvements in dose ho-
mogeneity and reduction in lung dose, the IMRT technique creates the possibility
to improve the field matching in the case of irradiation of the breast and lymph
nodes using multiple fields. The new breast irradiation technique has recently been
clinically introduced.
In chapter 3 a segmental intensity-modulated radiotherapy technique for the treat-
ment of oropharyngeal cancer was developed. The aim was to deliver three different
dose levels simultaneously: one to the lymph nodes (54 Gy), one to the CTV of
the primary tumor (66 Gy) and one to the GTV of the primary tumor (69 Gy).
The relation between the quality of a treatment plan and the number of beams
in combination with the number of segments was investigated in order to obtain
a clinically acceptable and deliverable plan. The dose distribution was therefore
optimized using beam geometries consisting of 3, 5, 7 and 9 equiangular beams.
The optimization procedure resulted in an optimized intensity map for each beam.
The optimized intensity map was divided in equidistant levels (5, 7, 10 or 15), in
97
98 Summary
order to vary the number of segments. The dose homogeneity within the target
volumes improved when the total number of segments increased and reached a
saturation level at approximately 150 segments. Seven beams were sufficient to
achieve the saturation level for dose homogeneity. The mean dose to the parotid
glands depended on the beam geometry and tumor location and did not depend
on the number of segments.
In chapter 4 the sparing of the parotid glands during the irradiation of oropha-
ryngeal cancer was further investigated. For three different IMRT strategies the
effect of reduction of positioning margins was investigated. Margins of 0, 3, 6 and
9 mm were therefore applied to the CTVs in order to obtain four planning target
volumes. The analysis of the three IMRT strategies resulted in: (1) an optimal
dose distribution in the PTV, (2) an optimal dose distribution in the PTV while
sparing the parotid gland and (3) more parotid gland sparing but at the expense of
the dose homogeneity in the PTV. The mean parotid dose increased linearly with
increasing margin by approximately 1.3 Gy per mm. As a result, the normal tissue
complication probability for xerostomia decreased when smaller margins were ap-
plied. Reducing the margin from 6 to 3 mm resulted in a relative NTCP reduction
of approximately 20%, showing the benefit of accurate position verification.
In chapter 5 the reliability and toxicity of the use of implanted gold markers for po-
sition verification during the irradiation of head-and-neck cancer was investigated.
The markers were visualized using an a-Si flat panel imager. Accurate position
verification is needed to deliver the dose to the right spot, and results in smaller
setup margins and therefore less dose to surrounding normal tissues (chapter 4).
Ten patients with localized head-and-neck tumors received two gold markers in the
parapharyngeal region. The acute and late radiation related toxicity were scored
prospectively, using common toxicity criteria. The marker location was detected in
portal images taken on average during 19 fractions. The inter-marker distance as
well as the interfraction motion were determined for all patients. No acute major
complications were observed. The gold seeds did not enhance the acute toxicity
grade. The markers were visible in all images. A small time trend was observed
in the inter-marker distance for three patients. For these patients at least one
marker was located in the pharyngeal mucosa or pharyngeal constrictor muscle.
Deep-seated gold markers did not show a time trend. The random error of the
geometric uncertainties obtained without correction during radiotherapy was 1-2
mm. It was concluded that the use of implanted gold markers for position verifi-
cation during radiotherapy of head-and-neck patients seems feasible. To avoid any
chance of migration, markers should be placed in deep muscular compartments.
In chapter 6 the intrafraction motions of the larynx were investigated during ra-
diotherapy. The larynx is a rather mobile organ in the head-and-neck region, and
motion may occur due to swallowing, breathing, or movement of the tongue. De-
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pending on the magnitude, duration and incidence, these motions may have clinical
consequences for the choice of margins around the clinical target volume. The in-
trafraction motions of the larynx were visualized using an a-Si flat panel imager.
Images were obtained every 200 ms, resulting in a movie of images for each beam.
Movies were obtained during 79% of the total number of radiotherapy fractions.
The total duration of swallowing was on average 0.45% (range 0.0 – 1.5%) of the
total irradiation time. Deviations of motions other than swallowing ranged from
0.3 to 11.5 mm. Some of these motions were sudden, while others were proba-
bly related to breathing, because the frequency of these motions was 8 – 20 per
minute. Due to the low incidence it is not necessary to apply an internal margin
to take into account displacements due to swallowing. A margin should however
be applied for other more frequent motions.
Two different segmental IMRT techniques have been developed in this thesis for
respectively irradiation of the breast and the oropharynx. Both techniques have
been implemented clinically. Various other improvements can be applied as have
been discussed in chapter 7. Part of them, concerning position verification for
head-and-neck cancer, have been investigated in this thesis.

Samenvatting
Radiotherapie is een behandelingsmethode voor patie¨nten met kanker waarbij ge-
bruik wordt gemaakt van straling. De meest voorkomende vorm van radiotherapie
is een behandeling met uitwendige stralenbundels. De hoogenergetische straling
zorgt voor schade aan het weefsel. Dit kan tot het gevolg hebben dat de cellen die
worden bestraald sterven. Bij radiotherapie wordt daarom geprobeerd een hoge
stralingsdosis te bereiken in de tumor om de kanker cellen te doden en tegelijker-
tijd een lage dosis in het gezonde weefsel te bereiken om daar zo min mogelijk
schade te veroorzaken. Bij uitwendige bestraling zal echter altijd ook een deel ge-
zond weefsel worden bestraald. Hierdoor onstaat er een kans op complicaties. De
dosis, die bij een behandeling wordt toegediend, hangt af van de eigenschappen
van de tumor zoals de dichtheid en de stralingsgevoeligheid van de tumorcellen.
In het ideale geval zijn alle eigenschappen van de tumor bekend en kan de dosis-
verdeling daarop worden aangepast.
Door de ontwikkelingen in de digitale beeldvormingtechnieken, zoals CT en MRI,
kan beter worden bepaald waar de tumor en de risico-organen zich bevinden in
het lichaam. Hierdoor is het mogelijk om een meer conformale dosisverdeling te
verkrijgen. Dat wil zeggen dat het hoge dosis gebied zich voornamelijk in de tumor
bevindt en dat het omringende weefsel zo min mogelijk dosis ontvangt. Een geavan-
ceerde vorm van radiotherapie is intensiteitgemoduleerde radiotherapie (IMRT).
Door het varie¨ren van de intensiteit binnen een stralingsbundel kan de dosisver-
deling worden aangepast. Hierdoor is het mogelijk om zeer conformale dosisverde-
lingen te verkrijgen waarbij de dosis in de tumor homogeen is verdeeld. Het is ook
mogelijk om de dosis binnen de tumor te varie¨ren en aan te passen aan karakte-
ristieken van de tumor. Er zijn beeldvormingtechnieken, zoals PET en functionele
MRI, die biologische informatie over de tumor geven. Het gebruik van deze in-
formatie voor radiotherapie moet echter nog verder worden ontwikkeld. Daarom
wordt op dit moment volstaan met het verhogen van de dosis in de tumor om zo
een beter behandelingsresultaat te bereiken.
Bij radiotherapie worden patie¨nten meestal in meerdere fracties bestraald, het is
daarom belangrijk dat de tumor zich elke keer op dezelfde plek bevindt ten op-
zichte van het bestralingsveld. Er zal echter een onzekerheid in de positie van de
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tumor zijn, bijvoorbeeld door positioneringsfouten of interne bewegingen van or-
ganen. Door deze positie onnauwkeurigheden kan een deel van de tumor buiten
het bestralingsveld komen te liggen waardoor de voorgeschreven dosis niet wordt
ontvangen. Om ervoor te zorgen dat de tumor altijd de gewenste dosis krijgt wordt
een extra marge rondom de tumor bestraald. Dit resulteert echter wel in extra do-
sis in het gezonde weefsel. Het is daarom belangrijk om de marge zo veel mogelijk
te reduceren. Daarvoor moet de positie van de tumor tijdens elke behandeling
worden geverifieerd en eventueel worden gecorrigeerd.
In dit proefschrift is IMRT toegepast op de bestraling van borstkanker. Het doel
daarbij is het bereiken van een homogene dosisverdeling. Daarnaast is een IMRT
techniek ontwikkeld voor de bestraling van oropharynx tumoren. Deze bestralings-
techniek is complexer dan die gebruikt wordt bij de bestraling van de borst, omdat
er meerdere doelvolumina moeten worden bestraald en verschillende risico-organen
(speekselklieren, hersenen, ruggenmerg) gespaard moeten worden. Bovendien krij-
gen de doelvolumina verschillende doses. Verder is een positieverificatie methode
voor hoofd-hals tumoren bekeken, met als doel de nauwkeurigheid van de behande-
ling te vergroten. De orgaanbewegingen van de larynx zijn onderzocht gedurende
de behandeling. Deze bewegingen kunnen bijdragen aan een extra marge die rond
de tumor moet worden genomen. Een gedetailleerde beschrijving per hoofdstuk
volgt in de volgende paragrafen.
In hoofdstuk 2 is een IMRT techniek ontwikkeld voor het bestralen van borst kan-
ker. Het doel hiervan is een homogene dosisverdeling te bereiken in de hele borst.
Bij deze techniek wordt het behandelingsveld opgedeeld in 4 segmenten om zo de
intensiteit te modelleren. De grootte en vorm van deze segmenten wordt bepaald
uit de radiologische dikte van het bestraalde volume. De meeste straling wordt ge-
geven door een groot open veld. De drie overige segmenten worden gebruikt om de
dosisverdeling homogeen te maken. Vergeleken met de conventionele behandeling
wordt met de IMRT techniek een meer homogene dosis in het doelvolume bereikt.
Bijkomend voordeel van de techniek is dat de gemiddelde dosis in de long is ver-
laagd met ongeveer 10 %. De IMRT techniek kan ook worden ge¨ımplementeerd in
de meer complexe borstbestralingen waarbij ook lymfeklieren worden meegenomen
in het bestralingsveld. De techniek is inmiddels klinisch in gebruik genomen.
In hoofdstuk 3 wordt een IMRT techniek voor de behandeling van oropharynx
kanker gepresenteerd. Bij deze techniek worden drie verschillende stralingsdoses
gegeven: e´e´n aan de lymfe klieren, e´e´n aan het CTV van de primaire tumor en e´e´n
aan het GTV van de primaire tumor. Tevens wordt er gezorgd voor een lage dosis
in het ruggenmerg en de hersenen, en wordt geprobeerd de dosis in de speeksel-
klieren te minimaliseren. De relatie tussen de kwaliteit van het behandelingsplan
en het aantal bundels in combinatie met het aantal segmenten is onderzocht om
een klinisch acceptabel plan te verkrijgen dat goed is af te stralen. De dosisver-
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deling is daarom uitgerekend voor 4 bundelgeometrie¨en, met respectievelijk 3, 5,
7, en 9 bundels. De optimalisatie resulteerde in een intensiteitverdeling voor elke
bundel. Door deze intensiteitverdeling op te delen in een verschillend aantal inten-
siteitsniveaus (5, 7, 10 of 15), kan een verschillend aantal segmenten per bundel
worden verkregen. De homogeniteit van de dosisverdeling in de doelvolumina blijkt
hoofdzakelijk afhankelijk van het totaal aantal segmenten dat wordt gebruikt en
verbetert niet meer wanneer meer dan 150 segmenten worden gebruikt. Tussen 100
en 150 segmenten verbetert de homogeniteit echter maar weinig. De bundelgeome-
trie met 7 bundels blijkt voldoende om een acceptabele dosisverdeling te bereiken.
De dosis in de speekselklieren blijkt niet afhankelijk van het aantal segmenten,
maar varieert wel per bundelgeometrie.
In hoofdstuk 4 wordt de sparing van de speekselklieren verder bestudeerd. Het
effect van marges voor onnauwkeurigheden in de positie op de dosis in de speeksel-
klieren wordt bestudeerd voor drie verschillende IMRT strategiee¨n. De drie strate-
giee¨n resulteerden in: (1) een optimale dosisverdeling in het PTV, (2) een optimale
dosisverdeling in het PTV en sparing van de speekselklieren en (3) verder sparing
van de speekselklieren maar ten koste van de dosisverdeling in het PTV. De dosis
in de speekselklieren neemt lineair toe met ongeveer 1.3 Gy per mm marge. Een
reductie in de marge van 6 mm naar 3 mm zou resulteren in een NTCP verlaging
van 20%. De conclusie luidt dat betere positieverificatie kan resulteren in minder
complicaties. De gegevens van deze studie en die beschreven in hoofdstuk 3 zijn
gebruikt om een studie op te zetten waarin bestudeerd wordt of IMRT resulteert
in een betere parotisfunctie dan de conventionele behandeling. Deze studie is in
2003 van start gegaan.
In hoofdstuk 5 wordt de toxiciteit en de betrouwbaarheid van ge¨ımplanteerde
goudmarkers bekeken voor positieverificatie van tumoren in het hoofd-hals gebied.
Het gebruik van goudmarkers moet leiden tot een nauwkeurigere positie bepaling,
wat nodig is om de dosis op de juiste plek af te geven. Door het verkleinen van on-
nauwkeurigheden in de positie van de patie¨nt kan de marge worden verkleind. Dit
kan leiden tot minder dosis aan het omliggende gezonde weefsel. In tien patie¨nten
zijn daarom twee markers ge¨ımplanteerd in het pharynx gebied. De acute en late
schade is prospectief gemeten. De locatie van de markers is bepaald met behulp
van beelden opgenomen met een “a-Si flat panel”. Gemiddeld zijn er beelden opge-
nomen gedurende 19 fracties per patie¨nt. De interfractie bewegingen en de afstand
tussen de markers is bepaald. De acute schade is niet vergroot door het gebruik
van goudmarkers. De afstand tussen de markers is groter geworden gedurende de
behandeling voor drie patie¨nten. Deze verandering is echter klein. Als er een ver-
groting in de afstand tussen de markers werd waargenomen, was altijd een marker
oppervlakkig ge¨ımplanteerd in de mucosa of in de musculus constrictor pharyn-
gis. Markers die dieper waren ge¨ımplanteerd, vertoonden geen verandering in de
onderlinge afstand en zitten dus vast. De random onnauwkeurigheid in de positie
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van de patie¨nt was, zonder correctie van de positie van de patie¨nt, 1-2 mm. Het
gebruik van goudmarkers voor de positieverificatie lijkt haalbaar.
In hoofdstuk 6 worden de bewegingen van de larynx bestudeerd tijdens de be-
straling met behulp van een a-Si detector. De larynx beweegt ten gevolge van
slikken, tongbewegingen en ademhalen. Afhankelijk van hun incidentie, grootte
en duur kunnen deze bewegingen consequenties hebben voor de marge die wordt
aangehouden voor onnauwkeurigheden in de positie. Met behulp van een a-Si de-
tector zijn filmpjes gemaakt gedurende de behandeling, waarbij elke 200 ms een
doorlichtingsbeeld is opgenomen. De filmpjes zijn gemaakt gedurende 79% van de
behandelingstijd. De incidentie van slikken blijkt laag, gemiddeld slikte een patie¨nt
gedurende 0,45% van de behandelingstijd. Er zijn echter wel andere bewegingen
met een grootte van 0,3 tot 11,5 mm waargenomen. Sommige bewegingen traden
plotseling op, andere werden waarschijnlijk veroorzaakt door de ademhaling omdat
de frequentie waarbij deze optraden 8-20 per minuut was. De incidentie van slikken
was laag, daarom hoeft daar geen extra marge voor te worden genomen. Met de
overige bewegingen moet echter wel rekening worden gehouden bij het bepalen van
een marge voor positie onnauwkeurigheden.
In dit proefschrift wordt de ontwikkeling van twee IMRT technieken beschreven,
voor respectievelijk radiotherapie voor borstkanker en oropharynxkanker. Beide
technieken zijn klinisch ge¨ımplementeerd. De beschreven technieken kunnen in de
toekomst nog worden verbeterd zoals beschreven in hoofdstuk 7. Een deel hiervan
is beschreven in dit proefschrift en betreft positieverificatie van het hoofd-hals
gebied (hoofdstuk 5 and 6).
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Ook wil ik de laboranten bedanken die mij geholpen hebben bij het maken van de
larynx filmpjes en de plaatjes van de marker patie¨nten. Mede dankzij hen was ik
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kamer te zetten waardoor het, ondanks het zuurstof tekort nog aardig uit te houden
was op onze kamer.
Tot slot mijn ouders, Otto en Corrie, en natuurlijk Lonneke, bedankt voor jullie
onvoorwaardelijke steun.
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